<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2024.1381180</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Gestational hypothyroxinemia induces ASD-like phenotypes in behavior, proinflammatory markers, and glutamatergic protein expression in mouse offspring of both sexes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gonz&#xe1;lez-Madrid</surname>
<given-names>Enrique</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1147459"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rangel-Ram&#xed;rez</surname>
<given-names>Ma. Andreina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2720480"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Opazo</surname>
<given-names>Mar&#xed;a C.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/305518"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>M&#xe9;ndez</surname>
<given-names>Luis</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/701782"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bohmwald</surname>
<given-names>Karen</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/229758"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bueno</surname>
<given-names>Susan M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/404453"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gonz&#xe1;lez</surname>
<given-names>Pablo A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/427054"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalergis</surname>
<given-names>Alexis M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/217683"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Riedel</surname>
<given-names>Claudia A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/492835"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Laboratorio de Endocrino-inmunolog&#xed;a, Departamento de Ciencias Biol&#xf3;gicas, Facultad de Ciencias de la Vida, Universidad Andr&#xe9;s Bello</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Facultad de Medicina Veterinaria y Agronom&#xed;a, Instituto de Ciencias Naturales, Universidad de las Am&#xe9;ricas</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Instituto de Ciencias Biom&#xe9;dicas, Facultad de Ciencias de la Salud, Universidad Aut&#xf3;noma de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Departamento de Endocrinolog&#xed;a, Facultad de Medicina, Pontificia Universidad Cat&#xf3;lica de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Roger Guti&#xe9;rrez-Ju&#xe1;rez, National Autonomous University of Mexico, Mexico</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Maria Jesus Herrero, San Sebastian University, Chile</p>
<p>Charles C Lee, Louisiana State University, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Claudia A. Riedel, <email xlink:href="mailto:claudia.riedel@unab.cl">claudia.riedel@unab.cl</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1381180</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Gonz&#xe1;lez-Madrid, Rangel-Ram&#xed;rez, Opazo, M&#xe9;ndez, Bohmwald, Bueno, Gonz&#xe1;lez, Kalergis and Riedel</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Gonz&#xe1;lez-Madrid, Rangel-Ram&#xed;rez, Opazo, M&#xe9;ndez, Bohmwald, Bueno, Gonz&#xe1;lez, Kalergis and Riedel</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>The prevalence of autism spectrum disorder (ASD) has significantly risen in the past three decades, prompting researchers to explore the potential contributions of environmental factors during pregnancy to ASD development. One such factor of interest is gestational hypothyroxinemia (HTX), a frequent condition in pregnancy associated with cognitive impairments in the offspring. While retrospective human studies have linked gestational HTX to autistic traits, the cellular and molecular mechanisms underlying the development of ASD-like phenotypes remain poorly understood. This study used a mouse model of gestational HTX to evaluate ASD-like phenotypes in the offspring.</p>
</sec>
<sec>
<title>Methods</title>
<p>To induce gestational HTX, pregnant mice were treated with 2-mercapto-1-methylimidazole (MMI), a thyroid hormones synthesis inhibitor, in the tap-drinking water from embryonic days (E) 10 to E14. A separate group received MMI along with a daily subcutaneous injection of T<sub>4</sub>, while the control group received regular tap water during the entire pregnancy. Female and male offspring underwent assessments for repetitive, anxious, and social behaviors from postnatal day (P) 55 to P64. On P65, mice were euthanized for the evaluation of ASD-related inflammatory markers in blood, spleen, and specific brain regions. Additionally, the expression of glutamatergic proteins (NLGN3 and HOMER1) was analyzed in the prefrontal cortex and hippocampus.</p>
</sec>
<sec>
<title>Results</title>
<p>The HTX-offspring exhibited anxious-like behavior, a subordinate state, and impaired social interactions. Subsequently, both female and male HTX-offspring displayed elevated proinflammatory cytokines in blood, including IL-1&#x3b2;, IL-6, IL-17A, and TNF-&#x3b1;, while only males showed reduced levels of IL-10. The spleen of HTX-offspring of both sexes showed increased Th17/Treg ratio and M1-like macrophages. In the prefrontal cortex and hippocampus of male HTX-offspring, elevated levels of IL-17A and reduced IL-10 were observed, accompanied by increased expression of hippocampal NLGN3 and HOMER1. All these observations were compared to those observed in the Control-offspring. Notably, the supplementation with T<sub>4</sub> during the MMI treatment prevents the development of the observed phenotypes. Correlation analysis revealed an association between maternal T<sub>4</sub> levels and specific ASD-like outcomes.</p>
</sec>
<sec>
<title>Discussion</title>
<p>This study validates human observations, demonstrating for the first time that gestational HTX induces ASD-like phenotypes in the offspring, highlighting the need of monitoring thyroid function during pregnancy.</p>
</sec>
</abstract>
<kwd-group>
<kwd>prenatal thyroid function</kwd>
<kwd>gestational hypothyroxinemia</kwd>
<kwd>neurodevelopment</kwd>
<kwd>autism spectrum disorder</kwd>
<kwd>behavior</kwd>
<kwd>inflammation</kwd>
<kwd>NLGN3 and HOMER1 expression</kwd>
</kwd-group>
<contract-num rid="cn001">1191300, 1231905, 1231851, 21202085</contract-num>
<contract-num rid="cn002">ICN2021_045</contract-num>
<contract-sponsor id="cn001">Agencia Nacional de Investigaci&#xf3;n y Desarrollo<named-content content-type="fundref-id">10.13039/501100020884</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Instituto Milenio en Inmunolog&#xed;a e Inmunoterapia<named-content content-type="fundref-id">10.13039/501100013928</named-content>
</contract-sponsor>
<counts>
<fig-count count="10"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="123"/>
<page-count count="22"/>
<word-count count="12502"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Translational Endocrinology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Maternal thyroid hormones (THs) - L-3,5,3&#x2019;,5&#x2019;-tetraiodothyronine (T<sub>4</sub>) and L-3,5,3&#x2019;-triiodothyronine (T<sub>3</sub>) - play pivotal roles in fetal growth and development (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). The developing fetus completely relies on maternal THs until approximately the 16<sup>th</sup> to 20<sup>th</sup> week of gestation, when its own thyroid gland matures and commences hormone synthesis (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). This dependency arises from maternal thyroid adaptations in pregnancy, which ensure adequate TH levels to fulfill the mother and fetal metabolic demands (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). The transplacental transfer of T<sub>4</sub> from the maternal circulation to the fetus is a particular critical event, given its greater propensity to cross the placental barrier compared to the biologically active T<sub>3</sub>. This facilitates the direct utilization of T<sub>4</sub> by fetal tissues or its conversion into T<sub>3</sub> (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). The increased maternal thyroid function in pregnancy also raises the gland susceptibility to dysfunction (<xref ref-type="bibr" rid="B7">7</xref>). In this context, gestational hypothyroxinemia (HTX) is an asymptomatic and highly frequent condition in early pregnancy, clinically defined by a reduction in T<sub>4</sub> (below the 5th percentile), while maintaining normal levels of T<sub>3</sub> and thyroid-stimulating hormone (TSH) in blood (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>). Gestational HTX has been an overlooked condition given its asymptomatic nature, nonetheless, is associated with neurocognitive impairments in the offspring, including lower intelligence quotient (IQ), auditory and motor difficulties, as well as an increased risk of attention deficit hyperactivity disorder (ADHD) in children (<xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>). Interestingly, retrospective studies in humans have reported that 5-to-8-year-old offspring gestated under HTX in the first trimester of pregnancy have a 2-to-4-fold increased likelihood of having autistic traits in behavior (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>).</p>
<p>Autism spectrum disorder (ASD) is defined as a sex-biased neurodevelopmental disorder (referring to gender-dependent differences in the occurrence or impact of ASD), characterized by social impairments and restricted repetitive patterns of interest and behavior (<xref ref-type="bibr" rid="B19">19</xref>). ASD is a heterogenous condition displaying a broad spectrum of cognitive abilities that often coexists with a spectrum of comorbidities, including epilepsy, feeding difficulties, constipation, attention-deficit hyperactivity disorder (ADHD), anxiety, and depression (<xref ref-type="bibr" rid="B19">19</xref>). The World Health Organization (WHO) recognizes ASD as a widespread condition, affecting approximately 1% of the global population (<xref ref-type="bibr" rid="B20">20</xref>). Over the past two decades, there has been a notable increase in its prevalence, shifting from 1 in 150 to 1 in 36 in the US. This rise is largely attributed to heightened awareness and advancements in early diagnosis methodologies (<xref ref-type="bibr" rid="B20">20</xref>). However, epidemiological and scientific studies indicate that ASD results from intricate interactions involving both genetic predispositions and environmental influences (<xref ref-type="bibr" rid="B21">21</xref>&#x2013;<xref ref-type="bibr" rid="B24">24</xref>). In this context, exposure to environmental factors during pregnancy has been identified as potential contributors to the prenatal induction of ASD, including environmental pollution (<xref ref-type="bibr" rid="B25">25</xref>&#x2013;<xref ref-type="bibr" rid="B27">27</xref>), the use of neuropsychiatric drugs or teratogens (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>), parental aging (<xref ref-type="bibr" rid="B30">30</xref>), and maternal inflammation (<xref ref-type="bibr" rid="B31">31</xref>). In addition to known thyroid disruptors such as perchlorate and pesticides, it has been demonstrated that these environmental factors that can also impair the adequate functioning of the maternal thyroid gland during pregnancy are associated with the emergence of ASD-like phenotypes in the offspring (<xref ref-type="bibr" rid="B32">32</xref>&#x2013;<xref ref-type="bibr" rid="B34">34</xref>).</p>
<p>Mouse models have been essential in studying ASD, reflecting some aspects of the disorder found in humans (<xref ref-type="bibr" rid="B35">35</xref>). These models are typically assessed based on behaviors like repetitive actions, anxiety, and social interaction (<xref ref-type="bibr" rid="B36">36</xref>). Despite the valuable contributions of these models in uncovering the biological mechanisms of autism, inconsistencies in behaviors are frequently noted, reflecting the variations observed in humans (<xref ref-type="bibr" rid="B37">37</xref>&#x2013;<xref ref-type="bibr" rid="B39">39</xref>).</p>
<p>Apart from the behavioral aspect, it has been reported that the expression of synaptic scaffolding proteins of glutamatergic neurons such as Homer protein homolog 1 (HOMER1) and Neuroligin 3 (NLGN3) are altered in the prefrontal cortex (PFC) and hippocampus of animal models with ASD like phenotype (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>). This is the case described in adult rats prenatally exposed to valproic acid (VPA) that also exhibit ASD-like behaviors (<xref ref-type="bibr" rid="B42">42</xref>). Moreover, both point mutations and altered expression of NLGN3 in mice have been shown to induce defective synaptic pruning and impaired hippocampal circuit-specific organization underlying the ASD-like phenotype (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>).</p>
<p>ASD-like alterations extend beyond the central nervous system. Immune dysregulation has been observed in both adult ASD patients and ASD-like rodent models assessed during adulthood (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Increased serum concentration of proinflammatory cytokines like interleukin (IL)-1&#x3b2;, IL-6, IL-17A, and TNF-&#x3b1; have been detected and are hypothesized to contribute to ASD pathophysiology. Consistently, anti-inflammatory cytokines like IL-10 and TGF-&#x3b2;1 are typically lower in ASD patients (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Additionally, elevated concentration of IL-17A in specific brain regions, which is considered as a neuroinflammatory-like trait, is associated with alterations in social cognition and appears to be a signature outcome of ASD physiopathology according to animal models displaying ASD-like behaviors (<xref ref-type="bibr" rid="B47">47</xref>). Moreover, ASD-related inflammatory profile can be accompanied by persistent dysregulation of both innate and adaptive immune response, as indicated by murine models. For instance, both the inbred mouse strain BTBR T<sup>+</sup>Itpr3<italic>
<sup>tf/J</sup>
</italic> (murine model of idiopathic ASD) and the adult mice gestated under maternal inflammation activation (MIA) model display increased population of macrophages, natural killers (NKs), and T cell populations in the spleen as compared to <italic>wild-type</italic> C57BL/6 mice (<xref ref-type="bibr" rid="B48">48</xref>&#x2013;<xref ref-type="bibr" rid="B50">50</xref>).</p>
<p>Despite human retrospective studies associating gestational HTX with ASD behavioral traits in the offspring, this notion has not been validated yet, at the same time that ASD-like cellular and molecular alterations have not been evaluated in this offspring. Therefore, by using a mouse model, this study aimed to establish a causal relationship between gestational HTX and ASD-like alterations in behavior, inflammatory biomarkers, and levels of specific glutamatergic proteins in the offspring of both sexes.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Animals</title>
<p>C57BL/6 mice obtained from The Jackson Laboratory, Bar Harbor, ME, USA were housed in cages with water, bedding, and chow (Prolab, RMH 3000) under standard conditions of a 12-hour light/dark cycle (lights on at 8:00 AM) and a temperature of 22&#xb0;C at the animal facility of the Facultad de Ciencias de la Vida, Universidad Andr&#xe9;s Bello (Santiago, Chile). All experimental procedures and care were performed according to current regulations and guidelines of the Animal Welfare Committee of the Facultad de Ciencias de la Vida (Bioethics approval certificate number 012/2021) and Agencia Nacional de Investigaci&#xf3;n y Desarrollo (ANID). Daily supervision of mice was performed by a veterinarian. Mice were euthanized by inhaling 5% isoflurane/O<sub>2</sub> according to AVMA guidelines (<xref ref-type="bibr" rid="B51">51</xref>).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Induction of gestational hypothyroxinemia</title>
<p>Gestational HTX was induced in pregnant mice according to previous reports (<xref ref-type="bibr" rid="B52">52</xref>&#x2013;<xref ref-type="bibr" rid="B55">55</xref>). Six- to eight-week-old C57BL/6 mice were mated in a proportion of 2 females and 1 male. The next day, a vaginal smear was collected and analyzed to search for spermatozoa. Mice with a positive smear were considered pregnant, and that day was referred to as embryonic day 1 (E1). Each dam was individually placed in a cage. On E10, pregnant mice were randomly distributed into three groups (N = 7 pregnant mice per group). The first group received regular tap water during the entire pregnancy (untreated dams); therefore, gestation was conducted under euthyroid conditions. The second group received 0.025% w/v of 2-mercapto-1-methylimidazole (methimazole, MMI) (M8506, Sigma-Aldrich, USA) in the drinking water from E10 to E14 (MMI-treated dams). To reverse the MMI-induced phenotypes, the third group was treated with 0.025% w/v MMI along with a daily subcutaneous injection of 25 &#x3bc;g/kg of T<sub>4</sub> dissolved in PBS from E10 to E14 (MMI+T<sub>4</sub>-treated dams) (<xref ref-type="bibr" rid="B52">52</xref>&#x2013;<xref ref-type="bibr" rid="B55">55</xref>). This treatment aimed to demonstrate that the observed effects induced by MMI are due to maternal T<sub>4</sub> reduction and not a side effect of MMI. Untreated and MMI-treated dams did not receive a vehicle intraperitoneal injection to avoid the related stress of a daily injection. Both the MMI and MMI+T<sub>4</sub> treatments were administered daily from E10 to E14 at 9:00 AM. The water for untreated dams was also renewed during E10 to E14. The bottles containing MMI solution were prepared daily with fresh tap water and protected from light. Consequently, the experimental groups of this work were the respective progenies named after the mother&#x2019;s treatment: Control-offspring, HTX-offspring, and HTX+T<sub>4</sub>-offspring.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Determination of thyroid hormones</title>
<p>To verify the correct induction of gestational HTX, blood samples were collected from the facial vein of each pregnant mouse on E14 and total (t)THs and TSH were quantified. Additionally, a blood sample was also obtained from each adult mouse on postnatal day 50 (P50) to evaluate thyroid function. Serum was separated from the blood samples by centrifugation at 1,000 xg for 15&#xa0;min at 4&#xb0;C. Levels of tT<sub>3</sub> and TSH were quantified by sandwich ELISA using mouse CUSABIO&#xae; ELISA kits (catalog N&#xb0;E05086m and N&#xb0;E05116m, respectively) following the manufacturer&#x2019;s instructions. Concurrently, tT<sub>4</sub> serum levels were determined by chemiluminescence in an external certified veterinary laboratory (LQCE, Santiago de Chile). After quantification, the tT<sub>4</sub> range for MMI-treated dams was established at [0.1 &#x2013; 1.9] (&#x3bc;g/dL), whereas the range of tT<sub>4</sub> in the untreated dams was [2.2 &#x2013; 4.5] (&#x3bc;g/dL). Since the administration of tT<sub>4</sub> during MMI treatment is expected to restore their levels and reverse the induced phenotype, the accepted tT<sub>4</sub> range in the MMI+T<sub>4</sub>-treated dams was set equal to that of the untreated group ([2.2 &#x2013; 4.5] (&#x3bc;g/dL)) (<xref ref-type="bibr" rid="B52">52</xref>&#x2013;<xref ref-type="bibr" rid="B55">55</xref>).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Behavioral testing</title>
<p>Control, HTX, and HTX+T<sub>4</sub> offspring were weaned on P28. To mitigate the impact of the &#x201c;litter effect&#x201d;, experimental groups were formed by randomly selecting 2-3 mice of each sex from each litter. Consequently, each group comprised 30 mice, conformed by 15 females and 15 males. Mice of the same sex were housed together in cages (4-5 mice per cage) from weaning until behavioral assessment. Behavioral testing was conducted during adulthood (from P55 to P64), specifically during the dark phase of the circadian cycle (between 9.00 AM and 2.00 PM), consistent with a previous report of behavioral assessment in mice (<xref ref-type="bibr" rid="B56">56</xref>). The sequence of behavioral testing was arranged as follows: marble burying (MB) on P55, elevated plus maze (EPM) on P56, tube dominance test from P57 to P63 (considering training and confrontation steps), and three-chamber social preference test on P64. The behavioral performance of each mouse in the EPM, tube dominance, and three-chamber tests was conducted under 60 decibels (dB) of white noise and recorded using an FHD 1080p/30 fps camera. Data were manually scored and analyzed by three trained investigators blinded to each experimental group.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Marble burying test</title>
<p>MB was performed to analyze repetitive/persistent behavior (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). Each mouse was placed inside the testing cage (arena size: 24&#xa0;cm x 17.2&#xa0;cm, wood chips bedding depth: 5&#xa0;cm) containing 12 marbles arranged in four columns of three marbles at equidistant distances. After 30&#xa0;min of exploration, each mouse was returned to its respective cage. The number of buried marbles was counted, considering them buried when 2/3 of their volume was concealed within the wood chips.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Elevated plus maze test</title>
<p>The elevated plus maze (EPM) test was employed to analyze anxious-like behavior (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). Each mouse was placed in the center of a suspended cross-shaped maze consisting of two open and two closed arms (25&#xa0;cm long x 7&#xa0;cm wide x 24.5&#xa0;cm high walls of closed arms). After 5 minutes of exploration, each mouse was returned to its respective cage. The number of entries into both the open and closed arms, as well as the time spent in each arm, were recorded. An entrance was only considered valid when all four paws of the mouse crossed the boundary of the maze center into an open or closed arm.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Tube dominance test</title>
<p>The tube dominance test was used to assess aggressive social interaction (<xref ref-type="bibr" rid="B61">61</xref>). A hollowed transparent Plexiglas tube measuring 30&#xa0;cm in length and 2.5&#xa0;cm in diameter was used. Two mice from distinct experimental group were introduced to the tube from opposite directions. The critical point occurs when both mice meet in the middle of the tube, and one must retreat to exit, thereby revealing a dominant or subordinate status based on the species hierarchy theory. The training step was conducted over three consecutive days (from P57 to P59) with the goal of teaching each mouse that crossing the tube is the only way to exit without backing up. Subsequently, the testing stage took place over four consecutive days (from P60 to P63). During the confrontation stage, mice from the Control-offspring were paired with those from the HTX-offspring group, the HTX-offspring mice were paired with the HTX+T<sub>4</sub>-offspring mice, and the Control-offspring mice were paired with the HTX+T<sub>4</sub>-offspring mice in a pairwise fashion. Confrontations were conducted between mice of the same sex, with pairs randomly chosen and confronted three times per day, rotating the initial entry position to minimize bias. After each confrontation, mice were returned to their respective cages to reduce the immediate impact of recent winning or losing. The number of wins for each mouse was recorded, and the total number of wins after four days was used as an indicator of their social status, distinguishing between dominant or subordinate.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Three-chamber social preference test</title>
<p>The three-chamber social preference test was conducted to assess social interaction abilities (<xref ref-type="bibr" rid="B62">62</xref>). Mice were first habituated per 1&#xa0;h to the three-chamber device (a plexiglass box of 102&#xa0;cm length x 47&#xa0;cm width x 45&#xa0;cm height). The three-chambered apparatus consisted of two lateral compartments, each containing one inverted wire cup, along with one empty central compartment. During the pre-test, each mouse was allowed to acclimate to the setup for 10 minutes. Then, the first phase of the test was initiated. An inanimate object was placed under one cup (named &#x201c;nonsocial stimulus&#x201d;), while an unfamiliar mouse, matched in terms of age and sex, was placed under the other cup (named &#x201c;social stimulus&#x201d;). Each mouse was then positioned in the central compartment of the three-chamber device and allowed to transit between the nonsocial and social compartments for 10 minutes. After that time, mice were returned to their respective cages. In the second phase of the test, the nonsocial stimulus was replaced with a second unfamiliar, age- and sex-matched mouse (also named &#x201c;<italic>de novo</italic> stimulus&#x201d; or &#x201c;Stranger 2&#x201d;), while maintaining the first strange mouse now renamed &#x201c;Stranger 1&#x201d;. Each mouse was allowed to transit between the Stranger 1 and Stranger 2 compartments for 10&#xa0;min. The following parameters were registered: the time that each mouse spent in the social, nonsocial, and <italic>de novo</italic> compartments, the time of direct interaction with the social, nonsocial, and <italic>de novo</italic> stimulus, and the number of entrances to each compartment. Direct interaction was defined as the presence of the mouse within a diameter of 5&#xa0;cm around each cup. Similar to the EPM test, an entry was considered when all four legs of the mouse crossed the center of the chamber toward one of the lateral compartments.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Cytokine determination by sandwich ELISA</title>
<p>On the day following the last behavioral test (P65), the Control, HTX, and HTX+T<sub>4</sub> offspring were euthanized to obtain the blood, brain, and spleen. Blood was collected via cardiac puncture and allowed to clot at room temperature for 25-30 minutes. Afterward, serum was isolated by centrifugation (1,000 xg, 15 minutes at 4&#xb0;C), aliquoted, and stored at -80&#xb0;C until further analysis. Brains were dissected to isolate the prefrontal cortex (PFC) and hippocampus from the telencephalon, following a standardized mouse brain dissection protocol (<xref ref-type="bibr" rid="B63">63</xref>). Both tissues were homogenized in radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 0.1% Triton X-100) supplemented with phosphatase and protease inhibitors (1 mM Na<sub>3</sub>VO<sub>4</sub>, 1 mM NaF, 30 mM sodium pyrophosphate, and 1 mM PMSF). After a 30-minute incubation on ice, the homogenates were centrifuged at 15,000 xg for 15 minutes at 4&#xb0;C. Total protein quantification from the supernatants was performed using the BCA method with a BSA standard curve (PierceTM, BCA&#x2122; 23225). Cytokines were quantified in serum samples of 100 &#x3bc;L and in brain tissue portions (0.5 mg of protein) using sandwich ELISA kits for specific cytokines: IL-1&#x3b2; (BioLegend, 432601), IL-6 (BioLegend, 431307), IL-17A (BioLegend, 432501), IL-10 (BioLegend, 555252), and TNF-&#x3b1; (BioLegend, 430901), following the manufacturer&#x2019;s instructions. Detection was conducted using a microplate spectrophotometer (Epoch&#x2122;). Serum cytokine concentrations were normalized to a volume of 100 &#x3bc;L, while cytokine levels in brain tissue portions were normalized to the amount of protein used for these measurements. Results are presented as pg/mL for cytokines in serum and as pg/mg for normalized brain-derived cytokines.</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Detection of NLGN3 and HOMER1 by western blot</title>
<p>The relative expression of the glutamatergic proteins NLGN3 (94 kDa) and HOMER1 (40 kDa) in the PFC and hippocampus was evaluated by western blot. Initially, 20 &#xb5;g of protein from both tissues was denatured at 95&#xb0;C for 5&#xa0;min and then separated on a 12.5% SDS-PAGE gel at 100&#xa0;V for 120&#xa0;min. The PageRuler Plus Prestained Protein Ladders of 10-250 kDa (Thermo Scientific&#x2122; 26619) and 10-180 kDa (Thermo Scientific&#x2122; 26616) were used to estimate the molecular weight of NLGN3 and HOMER1, respectively, and to monitor the progress of electrophoretic separation and electrotransference. Proteins were transferred onto nitrocellulose membranes (Thermo Scientific) for 1&#xa0;h at 100&#xa0;V on ice. Thereafter, membranes were blocked with 5% nonfat milk dissolved in Tris buffered saline with 0.1% Tween-20 (TBS-T, pH 7.6) for 1h at R.T with constant shaking. Membranes were separately probed with the primary antibodies anti-NLGN3 (2 &#x3bc;g/mL) (ab192880) and anti-HOMER1 (0,75 &#x3bc;g/mL) (ab211415), both prepared in 5% nonfat milk in TBS-T, overnight at 4&#xb0;C and constant rotation. Moreover, &#x3b1;-tubulin (1 &#x3bc;g/mL) (ab6046) was used as a loading control. On the next day, membranes were washed (3 times, 5&#xa0;min each) using TBS-T and then incubated with the secondary antibody anti-rabbit HRP-conjugated (1 &#x3bc;g/mL) (Bethyl A120-101P) in 5% nonfat milk in TBS-T for 1h at R.T and constant rotation. Membranes were washed (3 times, 5&#xa0;min each) using TBS-T and incubated with ECL detection substrate (Thermo ScientificTM 34076) for 5&#xa0;min. Bands were visualized and images were recorded using the Alliance Q9 Advanced chemiluminescence and spectral fluorescence imaging system (UVITEC Cambridge). Band intensities were analyzed using ImageJ software (NIH, Bethesda, MD, USA) and the relative expression of NLGN3 and HOMER1 was normalized to &#x3b1;-tubulin.</p>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Total splenocytes isolation</title>
<p>Spleens were separately placed in fresh RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS) and then homogenized through a 70 &#xb5;m cell strainer. Cell suspensions were centrifuged at 460 xg for 5&#xa0;min at 4&#xb0;C and then treated for 5&#xa0;min at R.T with ammonium-chloride-potassium buffer (ACK, pH 7.2) to lyse erythrocytes. After two washes with fresh 1X PBS (5 mL each), total splenic leukocytes (also called splenocytes) were resuspended in 1 mL of PEB buffer (PBS 1X, 0.5% BSA, 2 mM EDTA), and counted using the Countess 3 Automated Cell Counters equipment (Thermo Fisher Scientific) using the trypan blue exclusion test of cell viability analysis (<xref ref-type="bibr" rid="B64">64</xref>).</p>
</sec>
<sec id="s2_12">
<label>2.12</label>
<title>Immune cell assessment by flow cytometry</title>
<p>Adaptative and myeloid immune cell populations from the splenocytes were analyzed by flow cytometry. A portion of 1.0&#xd7;10<sup>7</sup> splenocytes were stimulated <italic>in vitro</italic> with phorbol myristate acetate (PMA; 5 ng/mL), ionomycin (500 ng/mL), and brefeldin-A (BFA, 10 &#x3bc;g/mL) for 5&#xa0;h at 37&#xb0;C and 5% CO<sub>2</sub>. Cells were harvested by centrifugation (600 xg, 5&#xa0;min, 4&#xb0;C) and then incubated with the following antibodies for 45&#xa0;min at 4&#xb0;C to assess Treg and Th17 populations: anti-CD4-BUV395 (BD 563790), anti-CD25-PeCy7 (BioLegend 102016), and anti-IL-17A-APCCy7 (BD 560821). Cells were washed and fixed with 2% formaldehyde in PBS for 15&#xa0;min at R.T. After washing with PEB buffer, the cells were permeabilized using buffer IV (BD Phosflow 560746) during 15 minutes at 4&#xb0;C. Cells were then washed and incubated with anti-FOXP3-Pe (Invitrogen 12-5773-82) and anti-ROR&#x3b3;t-BV421 (BD 562894) during 45&#xa0;min at 4&#xb0;C. Antibodies were used at 0.2 mg/mL. Cells were washed and fluorescent beads (Thermo Fisher C36950) were added to each sample at a concentration of 667 beads/mL to determine the absolute number of events of interest. Absolute numbers of Treg and Th17 cells were also used to determine the Th17/Treg ratio as previously reported (<xref ref-type="bibr" rid="B65">65</xref>). Finally, 300,000 events per sample were recorded using the BD LSRFFortessa X-20 cytometer from the Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile. FlowJo software (version 10.8) was used to analyze the immune cell populations. Concurrently, to analyze myeloid immune cell populations, a portion of 1.0&#xd7;10<sup>7</sup> splenocytes were directly stained with the following antibodies to analyze myeloid immune cell populations: anti-CD45-FITC (BioLegend 109806), anti-CD3-PercpCy5.5 (BioLegend 100218), anti-CD11b-PeCy7 (Invitrogen 25-0112-82), anti-CD49b-APC (BioLegend 103515), and anti-NK1.1-BV605 (BioLegend 108739) for Natural killers (NKs); anti-CD45-FITC (BioLegend 109806), anti-F4/80-BUV395 (BD 565614), anti-CD80-BV605 (BioLegend 104729), and anti-CD68-PeCy7 (BioLegend 137015) for M1-like macrophages; and anti-CD45-FITC (BioLegend 109806), anti-F4/80-BUV395 (BD 565614), anti-CD163-APC (BioLegend 156705), and anti-CD206-BV421 (BioLegend 141717) for M2-like macrophages, during 45&#xa0;min at 4&#xb0;C and darkness. All antibodies were used at 0.2 mg/mL. Cells were washed and analyzed by flow cytometry as previously described.</p>
</sec>
<sec id="s2_13">
<label>2.13</label>
<title>Statistical analyses</title>
<p>Sample sizes were determined using G*Power 3.1.9.7 software, based on a previous report (<xref ref-type="bibr" rid="B66">66</xref>). For pregnant mice groups, one-way ANOVA in F tests was conducted, with an effect size set to 0.80, &#x3b1; set to 0.05, and a test power set to 0.80, and considering 3 groups. This calculation yielded a total sample size of 21, with 7 mice allocated to each group. For experimental groups (Control-offspring, HTX-offspring, and HTX+T<sub>4</sub>-offspring), sample size was determined using a mixed-effects model in F test ANOVA, with an effect size set to 0.5 (effect size specification according to Cohen, 1988 (<xref ref-type="bibr" rid="B67">67</xref>)), &#x3b1; set to 0.05, a test power set to 0.99, number of measurements set to 41 (comprising all independent measurements obtained from each evaluated parameter in this study) and considering 3 groups. This resulted in a total sample size of 90, distributing 30 mice per experimental group, and separating 15 mice per sex. This allocation of mice for behavioral assessment and subsequent molecular analysis on the same mice aligns with the reduction and refinement principles of the 3 Rs in bioethics (<xref ref-type="bibr" rid="B68">68</xref>). Data analysis and statistical tests were performed using Prism 9.0.2 software (GraphPad, Inc). Thyroid hormone levels were compared among pregnant mice groups using <italic>one-way</italic> ANOVA followed by Tukey&#x2019;s post-hoc test. To conduct multiple comparisons between experimental groups and both sexes for each parameter evaluated in this study, while mitigating the impact of the &#x201c;litter effect&#x201d;, a mixed-effects model was employed followed by Tukey&#x2019;s post-hoc test. This approach enhances the reliability and accuracy of the results, ensuring robust statistical analysis (<xref ref-type="bibr" rid="B69">69</xref>). Pearson correlation analysis was applied to associate maternal T<sub>4</sub> levels with all outcomes evaluated in the offspring. The results are presented as the mean &#xb1; standard error of the mean (SEM). Significance was established at <italic>p</italic>&lt;0.05. <italic>p</italic> values in figures and text are presented as follows: *<italic>p</italic>&lt;0.05, **<italic>p</italic>&lt;0.01, ***<italic>p</italic>&lt;0.001, and ****<italic>p</italic>&lt;0.0001.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Methimazole treatment during E10 and E14 induces hypothyroxinemia in dams</title>
<p>Gestational HTX was induced in pregnant mice by administering 0.025% w/v of methimazole (MMI) through the tap drinking water from embryonic day 10 (E10) to E14 (refer to Materials and methods). The E10 to E14 timeframe for MMI treatment was chosen because it is comparable to the first trimester of gestation in human brain development (<xref ref-type="bibr" rid="B70">70</xref>). MMI acts as an allosteric inhibitor of the thyroid peroxidase enzyme, hindering the coupling of molecular iodine to the tyrosine residues in the thyroglobulin molecule, thereby inhibiting the TH synthesis (<xref ref-type="bibr" rid="B52">52</xref>&#x2013;<xref ref-type="bibr" rid="B55">55</xref>). Several reports have shown that short-term administration of this drug at this concentration induces gestational HTX rather than gestational hypothyroidism (<xref ref-type="bibr" rid="B52">52</xref>&#x2013;<xref ref-type="bibr" rid="B55">55</xref>). To confirm the successful induction of gestational HTX in dams, the levels of tT<sub>4</sub>, tT<sub>3</sub>, and TSH were quantified from serum samples obtained on E14. Results are shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>. The levels of tT<sub>4</sub> in the MMI-treated dams were reduced compared to untreated dams, however, this decrease was reversed by the addition of T<sub>4</sub> during the MMI administration (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). Additionally, the levels of tT<sub>3</sub> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>) and TSH (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>) remained similar among untreated, MMI-treated, and MMI+T<sub>4</sub>-treated dams. The exclusive reduction in tT<sub>4</sub> confirmed the successful induction of HTX. Additionally, tT<sub>4</sub>, tT<sub>3</sub>, and TSH were quantified in the Control, HTX, and HTX+T<sub>4</sub> offspring of both sexes on P50. The results indicate that the levels of tT<sub>4</sub> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>) tT<sub>3</sub> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>) and TSH (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>) were unchanged across the groups and sexes, indicating that the MMI treatment did not impact the offspring&#x2019;s thyroid function in adulthood.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Methimazole treatment induces gestational hypothyroxinemia in pregnant mice, while adult offspring remain euthyroid. Levels of total TH and TSH were measured in blood samples obtained from the facial vein of Control, HTX, and HTX+T<sub>4</sub> dams on E14 and plotted at <bold>(A)</bold> tT<sub>4</sub>, <bold>(B)</bold> tT<sub>3</sub>, and <bold>(C)</bold> TSH. Furthermore, the same hormones were quantified in both female and male offspring from the three experimental groups on P50 <bold>(D-F)</bold> (see Materials and Methods section). <bold>(A-C)</bold> N = 7 pregnant mice per group. <bold>(D-F)</bold> N = 15 per group and sex. Data are presented as mean &#xb1; S.E.M. Differences between pregnant mice groups <bold>(A-C)</bold> were analyzed by <italic>one-way</italic> ANOVA and Tukey&#x2019;s post-hoc. (****<italic>p</italic>&lt;0.0001). Multiple comparisons between experimental groups and both sexes <bold>(D-F)</bold> were analyzed by Mixed-effects model and Tukey&#x2019;s post-hoc. Control-offspring: blue circles, HTX-offspring: red squares, and HTX+T<sub>4</sub>-offspring: green triangles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1381180-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Gestational HTX induces ASD-like behavioral alterations in adult offspring of both sexes</title>
<p>Retrospective studies in humans have associated gestational HTX with autistic behavioral traits in the offspring (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). However, comprehensive causal studies, along with an investigation into the cellular and molecular mechanisms underlying these ASD-like manifestations in the offspring, have yet to be conducted. Therefore, using a mouse model, the primary aim of this study was to validate the notion that gestational HTX leads to the development of ASD-like behavioral alterations in the offspring. Furthermore, considering potential sex-specific effects, both females and males were included in the exploration of these outcomes. For this purpose, four behavioral tests were employed to evaluate repetitive behavior, anxious-like behavior, and social interaction abilities in the HTX-gestated offspring of both sexes and compare their performance with that of Control and HTX+T<sub>4</sub> offspring of both sexes. Behavioral testing was performed during adulthood given it is known that the brain reaches maturity at synaptic level and behavior-relevant areas, enabling a more precise investigation of ASD-like associated cognitive functions (<xref ref-type="bibr" rid="B70">70</xref>). Data are provided in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>.</p>
<p>First, repetitive behavior was assessed using the marble burying test, where increased number of buried marbles compared to the control group indicates ASD-like repetitive behavior (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). Female and male Control, HTX, and HTX+T<sub>4</sub> offspring were individually placed in the testing cage containing twelve glass marbles for 30&#xa0;min to evaluate their burying behavior. After that time, mice were returned to their respective cages and the number of buried marbles was counted (see Materials and methods). The percentages of buried marbles are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1.1</bold>
</xref>. The representative images illustrate the buried marbles of both the female Control (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>), HTX (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>), and HTX+T<sub>4</sub> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>) offspring, as well as the male Control (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>), HTX (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>), and HTX+T<sub>4</sub> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2F</bold>
</xref>) offspring. Quantified data indicate that both female and male HTX-offspring significantly buried fewer marbles than the Control and HTX+T<sub>4</sub>-offspring (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2G</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.1</bold>
</xref>), suggesting the HTX-gestated offspring do not manifest a repetitive ASD-like behavior.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The HTX-gestated offspring of both sexes buried fewer marbles compared to the Control and HTX+T<sub>4</sub> offspring. To assess repetitive behavior, adult offspring from the three experimental groups underwent the marble burying test on P55. The number of buried marbles was recorded, and the average count per experimental group was calculated. Pictures of the marbles at time 0&#x2019; and 30&#x2019; of the male <bold>(A-C)</bold> and female <bold>(D-F)</bold> experimental groups are illustrated. <bold>(G)</bold> The graph shows the percentage of buried marbles. N = 15 per group and sex. Data are presented as mean &#xb1; S.E.M. Multiple comparisons between experimental groups and both sexes were analyzed by Mixed-effects model and Tukey&#x2019;s post-hoc. (****<italic>p</italic>&lt;0.0001). Control-offspring: blue circles, HTX-offspring: red squares, and HTX+T<sub>4</sub>-offspring: green triangles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1381180-g002.tif"/>
</fig>
<p>Since anxiety is a widespread comorbid condition in ASD (<xref ref-type="bibr" rid="B71">71</xref>), the second evaluated aspect was the anxious-like behavior through the elevated plus maze (EPM) test (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). Mice were individually placed in the cross-shaped maze and the time spent in both the open and closed arms and the number of entrances were registered (see Materials and methods). Results are shown in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.2</bold>
</xref>. The findings indicate that both female and male HTX-offspring spent considerably less time exploring the open arms (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.2a</bold>
</xref>), which was consistent with a lower number of entries into the open arms (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.2b</bold>
</xref>), compared to the Control and HTX+T<sub>4</sub> offspring. Conversely, both female and male HTX-offspring spent significantly more time hiding in the closed arms, compared to the Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.2c</bold>
</xref>). No differences in the number of entrances to the closed arms were detected across experimental groups and sexes (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.2d</bold>
</xref>). Considering that when mice spending more time hiding in the closed arms of the maze and less exposure to open spaces points to anxious-like behavior, these results suggest that the HTX-offspring manifests a behavior indicative of anxiety.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Female and male HTX-offspring exhibited anxious-like behavior. To assess anxious-like behavior, both male and female offspring from the three experimental groups were subjected to the elevated plus maze test on P56. <bold>(A)</bold> Percentage of time spent in open arms, <bold>(B)</bold> Number of entrances into the open arms, <bold>(C)</bold> Percentage of time spent in closed arms, and <bold>(D)</bold> Number of entrances into the closed arms. N = 15 per group and sex. Data are presented as mean &#xb1; S.E.M. Multiple comparisons between experimental groups and both sexes were analyzed by Mixed-effects model and Tukey&#x2019;s post-hoc. (*<italic>p</italic>&lt;0.05, **<italic>p</italic>&lt;0.01, ***<italic>p</italic>&lt;0,001, ****<italic>p</italic>&lt; 0.0001). Control-offspring: blue circles, HTX-offspring: red squares, and HTX+T<sub>4</sub>-offspring: green triangles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1381180-g003.tif"/>
</fig>
<p>Subsequently, two specific tests were employed to evaluate two different dimensions of social behavior. The first test was tube dominance, design to assess socially aggressive behavior, aiding in the differentiation between subordinate and dominant statuses based on the principles of the hierarchy species theory (<xref ref-type="bibr" rid="B61">61</xref>). The test involves positioning two mice from distinct experimental groups at opposite entrances of a transparent hollow tube and allowing them to enter. Once they meet in the middle, a confrontation occurs, with one of the two compelling its opponent to retreat to exit. To evaluate the aggressive behavior of the HTX-gestated offspring, the following confrontation design was employed: Control-offspring vs. HTX-offspring, HTX+T<sub>4</sub>-offspring vs. HTX-offspring, and Control-offspring vs. HTX+T<sub>4</sub>-offspring (details in the Materials and Methods section). The percentage of wins for each experimental group was determined and provided in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.3</bold>
</xref>. The findings revealed that both female and male HTX-offspring displayed lower winning percentages when confronted with their respective female and male Control-offspring (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.3a</bold>
</xref>), and HTX+T<sub>4</sub>-offspring (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.3b</bold>
</xref>), suggesting that the HTX-gestated offspring have a subordinate status in the context of confrontation. Additionally, when Control-offspring was confronted with HTX+T<sub>4</sub>-offspring, regardless the sex, no significant differences in the winning percentage were detected (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.3c</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>The HTX-gestated offspring of both sexes exhibited a subordinate state in the tube dominance test. Offspring from the three experimental groups were submitted to the tube dominance test (from P57 to P63) to study their socially aggressive behavior (details in Materials and methods section). Confrontations were arranged as follows: <bold>(A)</bold> Control-offspring vs. HTX-offspring, <bold>(B)</bold> HTX-offspring vs. HTX+T<sub>4</sub>-offspring, and <bold>(C)</bold> Control-offspring vs. HTX+T<sub>4</sub>-offspring. The percentage of wins was plotted. N = 15 per experimental group and sex. Data are presented as mean &#xb1; S.E.M. Multiple comparisons between experimental groups and both sexes were analyzed by Mixed-effects model and Tukey&#x2019;s post-hoc. (*<italic>p</italic>&lt;0.05, ***<italic>p</italic>&lt;0,001, ****<italic>p</italic>&lt;0.0001). Control-offspring: blue circles, HTX-offspring: red squares, and HTX+T<sub>4</sub>-offspring: green triangles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1381180-g004.tif"/>
</fig>
<p>The second social aspect evaluated was the social interaction preferences through the three-chamber social preference test (<xref ref-type="bibr" rid="B62">62</xref>). Mice from the three experimental groups were exposed to interact with different stimuli placed in opposite compartments of a three-chamber device to assess social preferences (details provided in Materials and methods). The percentage of time spent in each compartment and the number of entrances are illustrated in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>2</bold>
</xref>. The percentage of time spent for direct interaction with each stimulus is shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4</bold>
</xref>. During the first step of the test, female HTX-offspring spent more time in the nonsocial compartment only compared to the HTX+T<sub>4</sub> offspring, while male HTX-offspring spent more time in the nonsocial compartment compared to both the Control and HTX+T<sub>4</sub> offspring (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4a</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1A</bold>
</xref>). Likewise, male HTX-offspring spent more time in the nonsocial compartment even compared to female HTX-offspring (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4a</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1A</bold>
</xref>). Additionally, only male HTX-offspring made a higher number of entrances to the nonsocial compartment (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4a</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1B</bold>
</xref>) and spent more time directly interacting with the nonsocial stimulus compared to both the Control and HTX+T<sub>4</sub> offspring and even compared to female HTX-offspring (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1.4c</bold>
</xref>). Conversely, only male HTX-offspring spent less time in the social compartment (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4d</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1C</bold>
</xref>), however, the number of entrances into the social compartment remained similar between experimental groups and sexes (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4e</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1E</bold>
</xref>). Finally, both female and male HTX-offspring spent less time directly interacting with the social stimulus compared to the Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4f</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Female and male HTX-offspring display decreased direct social interaction preference compared to Control-offspring and HTX+T<sub>4</sub>-offspring. Offspring from the three experimental groups were subjected to analyze their social interaction abilities with the three-chamber social preference test on P64 (see Materials and methods). In the &#x201c;Stranger 1&#x201d; step, mice were exposed to a nonsocial and a social stimulus. <bold>(A)</bold> Percentage of time of direct interaction with the nonsocial stimulus and <bold>(B)</bold> Percentage of time of direct interaction with the social stimulus. In the &#x201c;Stranger 2&#x201d; step, mice were exposed to interact with the social stimulus from the first step but now renamed as &#x201c;Stranger 1&#x201d; step and the nonsocial stimuli was replaced with a new social incentive named &#x201c;Stranger 2&#x201d;. <bold>(C)</bold> Percentage of time of direct interaction with the S1 stimulus and <bold>(D)</bold> Percentage of time of direct interaction with the S2 stimulus. N = 15 per group and sex. Data are presented as mean &#xb1; S.E.M. Multiple comparisons between experimental groups and sexes were analyzed by Mixed-effects model and Tukey&#x2019;s post-hoc. (**<italic>p</italic>&lt;0.01, ***<italic>p</italic>&lt;0,001, ****<italic>p</italic>&lt; 0.0001). Control-offspring: blue circles, HTX-offspring: red squares, and HTX+T<sub>4</sub>-offspring: green triangles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1381180-g005.tif"/>
</fig>
<p>In the second phase of the test, the nonsocial stimulus was replaced with a new stranger mouse (referred to as the &#x2018;<italic>de novo</italic> stimulus&#x2019; or &#x2018;Stranger 2&#x2019;), while maintaining the first stranger mouse, now renamed as &#x2018;Stranger 1&#x2019;. Despite no differences were identified in the time spent in the Stranger 1 compartment (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4g</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>), only male HTX-offspring made more entries to that compartment compared to Control and HTX+T<sub>4</sub> offspring (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4h</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2B</bold>
</xref>). Additionally, both female and male HTX-offspring spent more time directly interacting with the Stranger 1 stimulus compared to Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4i</bold>
</xref>). Conversely, HTX-offspring (both sexes) spent less time in the Stranger 2 compartment (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4j</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3C</bold>
</xref>), but only females displayed a lower number of entrances to the Stranger 2 compartment (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4k</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3D</bold>
</xref>). Finally, both female and male HTX-offspring spent less time directly interacting with the <italic>de novo</italic> stimulus compared to Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.4l</bold>
</xref>). Complementing these results with the first step, the HTX-gestated offspring show a reduced preference for interacting with the social stimuli but exhibit a stronger preference for interacting with the same social stimuli when the object is replaced with a second unfamiliar one in the second step of the test. These findings reinforce the notion of impaired interaction abilities resembling ASD-like behavior in this offspring.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Gestational HTX elevates proinflammatory markers in both female and male offspring</title>
<p>Beyond behavioral alterations, immune dysregulation has also been associated with ASD, mainly by the determination of proinflammatory cytokines in blood samples of patients and the examination of neuroinflammatory traits and immune cell populations in secondary lymphoid organs in mouse models (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Hence, we investigated whether gestational HTX leads to ASD-like inflammatory status in offspring.</p>
<p>After conducting the behavioral tests, mice were euthanized, and specific cytokines were measured from serum samples (refer to Materials and Methods) (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.1</bold>
</xref>). The results indicate that both female and male HTX-offspring had increased concentrations of the proinflammatory cytokines TNF-&#x3b1; (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.1a</bold>
</xref>), IL-6 (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-4.1b</bold>
</xref>), IL-1&#x3b2; (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.1c</bold>
</xref>), and IL-17A (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.1d</bold>
</xref>), in comparison to Control and HTX+T<sub>4</sub> offspring. Additionally, IL-1&#x3b2; was even higher in the male HTX-offspring than in females (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.1c</bold>
</xref>). The anti-inflammatory cytokine IL-10 was significantly reduced only in male HTX-offspring compared to male Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6E</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.1e</bold>
</xref>). The increased serum concentration of proinflammatory cytokines in the HTX-offspring is in concordance with ASD-like molecular features. Considering the neuroinflammatory component of ASD (<xref ref-type="bibr" rid="B47">47</xref>), IL-17A and its counterpart IL-10 were quantified in brain regions related to social cognition (prefrontal cortex (PFC) and hippocampus) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.2</bold>
</xref>). In the PFC, both female and male HTX-offspring had an increased concentration of IL-17A (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.2a</bold>
</xref>), while a reduction of IL-10 in the PFC was only observed in male HTX-offspring, compared to Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.2b</bold>
</xref>). Interestingly, the male Control-offspring had a higher content of IL-10 in the PFC compared to female Control-offspring (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.2b</bold>
</xref>). Moreover, IL-17A in the hippocampus was increased in HTX-offspring of both sexes (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.2c</bold>
</xref>), whereas IL-10 was reduced only in the hippocampus of male HTX-offspring compared to Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.2d</bold>
</xref>). These results suggest that the HTX-offspring exhibits a sex-dependent neuroinflammatory-like component which can also be indicative of an ASD-like phenotype.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Female and male HTX-offspring has an increased concentration of pro-inflammatory cytokines in blood, while only male showed a reduced concentration of IL-10. Offspring from the three experimental groups were euthanized on P65, and the blood was extracted by cardiac puncture. The serum was isolated and used as samples (100 &#x3bc;L each) for the following cytokines determination by using sandwich ELISA: <bold>(A)</bold> TNF-&#x3b1;, <bold>(B)</bold> IL-6, <bold>(C)</bold> IL-1&#x3b2;, <bold>(D)</bold> IL-17A, and <bold>(E)</bold> IL- 10.&#xa0;N = 15 per group and sex. Data are presented as mean &#xb1; S.E.M. Multiple comparisons between experimental groups and both sexes were analyzed by Mixed-effects model and Tukey&#x2019;s post-hoc. (*<italic>p</italic>&lt;0.05, ***<italic>p</italic>&lt;0,001, ****<italic>p</italic>&lt;0.0001). Control-offspring: blue circles, HTX-offspring: red squares, and HTX+T<sub>4</sub>-offspring: green triangles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1381180-g006.tif"/>
</fig>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>The HTX-gestated offspring of both sexes has higher levels of IL-17A in the prefrontal cortex and hippocampus than the control groups and reduced IL-10 only in males. Progenies of the three experimental groups were euthanized on P65, and PFC and hippocampus were isolated. Total proteins were extracted from these tissues and 0.5 mg per sample were used for the measurement of IL-17A and IL-10 by sandwich ELISA. <bold>(A)</bold> IL-17A in the PFC, <bold>(B)</bold> IL-10 in the PFC, <bold>(C)</bold> IL-17A in the hippocampus, and <bold>(D)</bold> IL-10 in the hippocampus. Data was normalized to mg of proteins. N = 15 per experimental group and sex. Data are presented as mean &#xb1; S.E.M. Multiple comparisons between experimental groups and both sexes were analyzed by Mixed-effects model and Tukey&#x2019;s post-hoc. (*<italic>p</italic>&lt;0.05, **<italic>p</italic>&lt;0.01, ***<italic>p</italic>&lt;0,001, ****<italic>p</italic>&lt;0.0001). Control-offspring: blue circles, HTX-offspring: red squares, and HTX+T<sub>4</sub>-offspring: green triangles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1381180-g007.tif"/>
</fig>
<p>Finally, to broaden our comprehension of the immunological aspect of the HTX-offspring regarding the proportion of immune cell populations (<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>), total splenocytes were isolated, and myeloid and specific T cells were assessed by flow cytometry. Total splenocytes were subjected to an <italic>in vitro</italic> stimulation with PMA, ionomycin, and BFA. Thereafter, harvested cells were labeled with appropriate antibodies to identify Tregs and Th17 cells and analyzed by flow cytometry (see Materials and methods). The results are presented in <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref> and the employed gating strategy for Treg and Th17 cell selection is shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;3A</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>B</bold>
</xref>, respectively. The findings revealed that both female and male HTX-offspring had a lower absolute number of CD4<sup>+</sup>CD25<sup>high</sup>FOXP3<sup>+</sup> cells (Tregs), compared to Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8A, B</bold>
</xref>). Conversely, an increased absolute number of CD4<sup>+</sup>IL-17A<sup>+</sup>ROR&#x3b3;t<sup>+</sup> cells (Th17) was observed in HTX-offspring of both sexes, also compared to Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8C, D</bold>
</xref>). Consistent with these findings, both female and male HTX-offspring had a higher Th17/Treg ratio (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8E</bold>
</xref>). Myeloid cells, particularly M1/M2-like macrophages and NK cells were also evaluated in splenocytes by flow cytometry. The results are depicted in <xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9</bold>
</xref> and the employed gating strategy is shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;4A-C</bold>
</xref>. Similarly, both female and male HTX-offspring had a higher absolute number of CD45<sup>+</sup>CD3<sup>-</sup>F4/80<sup>+</sup>CD80<sup>+</sup>CD68<sup>+</sup> cells (M1-like macrophages), than the Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f9">
<bold>Figures&#xa0;9A, B</bold>
</xref>). Nonetheless, no differences were observed in the absolute numbers of CD45<sup>+</sup>CD3<sup>-</sup>F4/80<sup>+</sup>CD206<sup>+</sup>CD163<sup>+</sup> cells (M2-like macrophages) (<xref ref-type="fig" rid="f9">
<bold>Figures&#xa0;9C, D</bold>
</xref>) and CD45<sup>+</sup>CD3<sup>-</sup>CD11b<sup>+</sup>NK1.1<sup>+</sup>CD49b<sup>+</sup> cells (NKs) (<xref ref-type="fig" rid="f9">
<bold>Figures&#xa0;9E, F</bold>
</xref>). These findings, in conjunction with the previous ones, indicate that the HTX-offspring also exhibits an imbalanced proportion of immune cells, overall pointing to an exacerbated proinflammatory status that aligns with an ASD-like phenotype.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>The HTX-offspring of both sexes has an imbalance in the Th17/Tregs ratio inclined towards increased Th17 cell number. Progenies from the three experimental groups were euthanized on P65, and spleens were removed. Total splenocytes were purified and a portion of these cells was <italic>in vitro</italic> stimulated using PMA-Ionomycin-BFA (see Materials and methods). The population of Tregs and Th17 were quantified by flow cytometry. <bold>(A)</bold> Representative dot plots of FOXP3-positive cells, <bold>(B)</bold> The graph shows the absolute number of FOXP3-positive cells, <bold>(C)</bold> Representative dot plots of ROR&#x3b3;t-positive cells, <bold>(D)</bold> the graph shows the absolute number of ROR&#x3b3;t-positive cells, and <bold>(E)</bold> the graph shows the Th17/Tregs ratio. N = 15 per group and sex. Data are presented as mean &#xb1; S.E.M. Multiple comparisons between groups and both sexes were analyzed by Mixed-effects model and Tukey&#x2019;s post-hoc. (*<italic>p</italic>&lt;0.05, **<italic>p</italic>&lt;0.01, ****<italic>p</italic>&lt;0,0001). Control-offspring: blue circles, HTX-offspring: red squares, and HTX+T<sub>4</sub>-offspring: green triangles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1381180-g008.tif"/>
</fig>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>M1-type macrophages are increased in HTX-offspring&#x2019;s spleen of both sexes, while M2-type macrophages and NK cells remain similar among experimental groups. Splenic innate immune cells were quantified by flow cytometry (see Materials and Methods). <bold>(A)</bold> Representative dot-plots of CD68-positive cells, <bold>(B)</bold> The graph shows the absolute number of CD68-positive cells, <bold>(C)</bold> Representative dot-plots of CD206/CD163 double-positive cells, <bold>(D)</bold> the graph shows the absolute number of CD206/CD163 double-positive cells, <bold>(E)</bold> Representative dot-plots of NK1.1/CD49b double-positive cells, and <bold>(F)</bold> the graph shows the absolute number of NK1.1/CD49b double-positive cells. N = 15 per group and sex. Data are presented as mean &#xb1; S.E.M. Multiple comparisons between experimental groups and both sexes were analyzed by Mixed-effects model and Tukey&#x2019;s post-test. (***<italic>p</italic>&lt;0.001, ****<italic>p</italic>&lt;0.0001). Control-offspring: blue circles, HTX-offspring: red squares, and HTX+T<sub>4</sub>-offspring: green triangles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1381180-g009.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Gestational HTX increases the expression of hippocampal NLGN3 and HOMER1 in male offspring</title>
<p>The effects of gestational HTX on offspring behavior and immune status encourage exploration into whether this condition also affects the expression of glutamatergic proteins, such as NLGN3 and HOMER1, whose altered levels are associated with ASD-like behaviors in mice (<xref ref-type="bibr" rid="B72">72</xref>). For this purpose, total proteins from both the PFC and hippocampus were isolated, and the expression of NLGN3 and HOMER1 was determined by using western blot (refer to Material and methods for details). The results of this analysis are shown in <xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10</bold>
</xref>.</p>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>The expression of hippocampal NLGN3 and HOMER1 is increased in male HTX-offspring. Progenies from the three experimental groups were euthanized on P65, and prefrontal cortex (PFC) and hippocampus were isolated. Total proteins were extracted from these tissues and the relative expression of Neuroligin 3 (NLGN3) and HOMER1 from the PFC and hippocampus were evaluated by western blot in each experimental group. <bold>(A)</bold> Representative photography of the western blot of NLGN3 from the PFC, <bold>(B)</bold> the graph shows the normalized relative expression of NLGN3 in the PFC, <bold>(C)</bold> representative photography of the western blot of NLGN3 from the hippocampus, <bold>(D)</bold> the graph shows the normalized relative expression of NLGN3 from the hippocampus, <bold>(E)</bold> representative photography of the western blot of HOMER1 from the PFC, <bold>(F)</bold> the graph shows the normalized relative expression of HOMER1 in the PFC, <bold>(G)</bold> representative photography of the western blot of HOMER1 from the hippocampus, and <bold>(H)</bold> the graph shows the normalized relative expression of HOMER1 from the hippocampus. N =15 per group and sex. a.u means arbitrary units. Data are presented as mean &#xb1; S.E.M. Multiple comparisons between experimental groups were analyzed by Mixed-effects model and Tukey&#x2019;s post-hoc. (*<italic>p</italic>&lt;0.05, **<italic>p</italic>&lt;0.01, ***<italic>p</italic>&lt;0.001, ****<italic>p</italic>&lt;0.0001). Control-offspring: blue circles, HTX-offspring: red squares, and HTX+T<sup>4</sup>-offspring: green triangles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1381180-g010.tif"/>
</fig>
<p>The expression levels of NLGN3 in the PFC were comparable among the HTX, Control, and HTX+T<sub>4</sub> offspring, regardless the sex (<xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10A, B</bold>
</xref>), however, only male HTX-offspring showed a significant increase in the expression levels of hippocampal NLGN3 compared to male Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10C, D</bold>
</xref>). At the same time, the expression levels of hippocampal NLGN3 in male HTX-offspring was significantly higher than in female HTX-offspring (<xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10C, D</bold>
</xref>). On the other hand, the expression levels of HOMER1 in the PFC was similar when comparing the HTX, Control, and HTX+T<sub>4</sub> offspring of the same sex (<xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10E, F</bold>
</xref>), however, it is worth noting that the expression levels of HOMER1 in the PFC of males in the Control, HTX, and HTX+T<sub>4</sub> offspring was simultaneously higher than in females of the Control, HTX, and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10E, F</bold>
</xref>). Finally, only male HTX-offspring showed higher expression levels of hippocampal HOMER1 compared to male Control, HTX+T<sub>4</sub>, and even female HTX-offspring (<xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10G, H</bold>
</xref>). These results indicate that the effects of gestational HTX on the offspring go beyond behavior and immune response, but also induce sex-dependent alterations in the expression of glutamatergic proteins, which collectively can be interpreted as ASD-like outcomes.</p>
<p>Additionally, the results of this work were also collectively analyzed (without separation by sex) and are presented from <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;5</bold>
</xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1">
<bold>14</bold>
</xref>.</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Maternal T<sub>4</sub> levels are correlated with specific behavioral and proinflammatory outcomes of the offspring</title>
<p>In this study, gestational HTX was defined as a reduction of maternal tT<sub>4</sub> within a range of [0.1 &#x2013; 1.9] (&#x3bc;g/dL), whereas the Control and HTX+T<sub>4</sub> ranges were established at [2.2 &#x2013; 4.5] (&#x3bc;g/dL). Nonetheless, it is relevant to note that these ranges were defined within the context of natural variability. For this reason, to investigate whether maternal T<sub>4</sub> levels could influence the development of ASD-like phenotypes in the offspring, a Pearson correlation analysis was conducted (<xref ref-type="bibr" rid="B73">73</xref>) to measure the association between maternal T<sub>4</sub> levels (considering all HTX, Control, and HTX+T<sub>4</sub> dams&#x2019; levels) and all the observed outcomes (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Maternal T<sub>4</sub> is correlated with ASD-like outcomes of the offspring.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Parameter</th>
<th valign="middle" align="center">ASD-like outcomes</th>
<th valign="middle" align="center">
<italic>r</italic>
</th>
<th valign="middle" align="center">
<italic>p</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="6" align="center">Maternal T<sub>4</sub> levels</td>
<td valign="middle" align="center">%Buried Marbles</td>
<td valign="middle" align="center">0,578</td>
<td valign="middle" rowspan="6" align="center">(****)<break/>
<italic>p</italic>&lt;0.0001</td>
</tr>
<tr>
<td valign="middle" align="center">N&#xb0; entries to open arms</td>
<td valign="middle" align="center">0,591</td>
</tr>
<tr>
<td valign="middle" align="center">Direct interaction with Social stimuli</td>
<td valign="middle" align="center">0,559</td>
</tr>
<tr>
<td valign="middle" align="center">IL-1&#x3b2; in serum</td>
<td valign="middle" align="center">-0,641</td>
</tr>
<tr>
<td valign="middle" align="center">IL-17A in serum</td>
<td valign="middle" align="center">-0,721</td>
</tr>
<tr>
<td valign="middle" align="center">IL-10 in serum</td>
<td valign="middle" align="center">0,578</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Pearson correlations were employed to associate maternal T<sub>4</sub> with all measured outcomes in the offspring of both sexes. The table displays correlations specifically within the range of 0.5 to 1.0, representing &#x201c;medium to high&#x201d; associations.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The results revealed significant positive correlations between maternal T<sub>4</sub> levels and the percentage of buried marbles (<italic>r</italic>=0.578, <italic>p</italic>&lt;0.00001), the number of entries into open arms during the EPM test (<italic>r</italic>=0.591, <italic>p</italic>&lt;0.00001), the percentage of time directly interacting with social stimuli in the Three-chamber test (<italic>r</italic>=0.559, <italic>p</italic>&lt;0.00001), and IL-10 concentration in serum (<italic>r</italic>=0.578, <italic>p</italic>&lt;0.00001). Conversely, significant inverse associations were noted between maternal T<sub>4</sub> levels and IL-1&#x3b2; (<italic>r</italic>=-0.641, <italic>p</italic>&lt;0.00001) and IL-17A (<italic>r</italic>=-0.721, <italic>p</italic>&lt;0.00001) levels in the blood (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). These associations suggests that maternal thyroid status influence the development of ASD-like phenotypes in the offspring.</p>
<p>Additional significant correlations between behavioral parameters and proinflammatory outcomes are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;17A, B</bold>
</xref>. Interestingly, the IL-1&#x3b2; levels, regardless of sex, were negatively correlated with specific behavioral parameters, including the percentage of buried marbles in the MB test (<italic>r</italic>=-0.580, <italic>p</italic>&lt;0.00001), the number of entries into the open arms in the EPM test (<italic>r</italic>=-0.600, <italic>p</italic>&lt;0.00001), the time of direct interaction with the social stimuli in the three-chamber test (<italic>r</italic>=-0.586, <italic>p</italic>&lt;0.00001), and positively correlated with the time of direct interaction with the Stranger 1 stimuli in the three-chamber test (<italic>r</italic>=0.653, <italic>p</italic>&lt;0.00001) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>). At the same time, the IL-1&#x3b2; levels were positively correlated with other proinflammatory outcomes, including the blood levels of IL-17A (<italic>r</italic>=0.632, <italic>p</italic>&lt;0.00001) and TNF-&#x3b1; (<italic>r</italic>=0.649, <italic>p</italic>&lt;0.00001), and the number of M1-like macrophages in the spleen (<italic>r</italic>=0.588, <italic>p</italic>&lt;0.00001) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>). Similar trends are evident in the associations between the blood levels of IL-6, IL-17A, and TNF-&#x3b1; with behavioral parameters (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>). Moreover, the levels of IL-17A in the hippocampus were negatively correlated with the percentage of buried marbles (<italic>r</italic>=-0.640, <italic>p</italic>&lt;0.00001), while the IL-17A levels in the PFC were positively correlated with the levels of TNF-&#x3b1; in blood (<italic>r</italic>=0.634, <italic>p</italic>&lt;0.00001) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>). No significant correlations were identified regarding the levels of IL-10 in either the PFC or hippocampus (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>). At the cellular level, the Th17/Tregs ratio was negatively correlated with the MB test performance (<italic>r</italic>=-0.603, <italic>p</italic>&lt;0.00001), while the number of M1-like macrophages showed a negative correlation with the number of entries to the exposed arms in the EPM test (<italic>r</italic>=-0.557, <italic>p</italic>&lt;0.00001), and a positive correlation with the direct interaction time with the Stranger 1 stimuli (<italic>r</italic>=0.666, <italic>p</italic>&lt;0.00001), and the blood levels of IL-1&#x3b2; (<italic>r</italic>=0.588, <italic>p</italic>&lt;0.00001), IL-6 (<italic>r</italic>=0.582, <italic>p</italic>&lt;0.00001), IL-17 (<italic>r</italic>=0.636, <italic>p</italic>&lt;0.00001), and TNF-&#x3b1; (<italic>r</italic>=0.630, <italic>p</italic>&lt;0.00001) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>In this work, we present evidence indicating that gestational HTX induces long-term effects in offspring of both sexes. These effects include ASD-like alterations in behavior, elevated proinflammatory markers in blood, spleen, prefrontal cortex, and hippocampus, as well as sex-dependent alterations in the expression of glutamatergic proteins NLGN3 and HOMER1 in the hippocampus.</p>
<p>In light of previous evidence from associative studies in humans linking gestational HTX with ASD traits in offspring (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>), a variety of behavioral tests were conducted to evaluate ASD-like behaviors in mice gestated with HTX, with the intention of validating such association, and considering both females and males to explore potential sex-specific effects (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2</bold>
</xref>
<bold>-</bold>
<xref ref-type="fig" rid="f5">
<bold>5</bold>
</xref>). The reason for utilizing at least four tests is that the ASD-like behaviors may not consistently manifest across all tests. This variability is evident from behavioral assessments conducted on genetically modified mouse models associated with ASD-like conditions, such as <italic>Ube3a</italic>, <italic>Pten</italic>, <italic>Nlgn3</italic>, <italic>Shank3</italic>, <italic>Mecp2</italic>, and <italic>Fmr1</italic> (<xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B75">75</xref>). Additionally, chemically induced ASD-like models during gestation, including the use of neuropsychiatric drugs like valproic acid (VPA) and molecules mimicking infections such as lipopolysaccharide (LPS) and polyinosinic:polycytidylic acid (poly(I:C)), have also exhibited variability in the expression of ASD-like behaviors (<xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B75">75</xref>).</p>
<p>In the marble burying test, it is expected that mice exhibiting repetitive behavior bury an increased number of marbles than control mice (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). Nonetheless in this case, both female and male HTX-offspring significantly buried fewer glass marbles compared to Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1-1.1</bold>
</xref>), suggesting that the HTX-offspring does not exhibit repetitive behavior. In contrast, it has been reported that mouse offspring exposed to other <italic>in utero</italic> alterations, including maternal inflammation (MIA-offspring) and the exposition to teratogens such as VPA (VPA-offspring), bury more marbles than the control in the MB test, inferring that these mice display repetitive behavior (<xref ref-type="bibr" rid="B76">76</xref>&#x2013;<xref ref-type="bibr" rid="B78">78</xref>). Despite this result, it is reported that the behavior of the HTX-offspring in the MB test can be associated with impaired hippocampal function in terms of impaired synaptic transmission (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). This finding further supports previous research conducted on the HTX-gestated offspring, which showed deficient long-term potentiation (LTP) induction and compromised spatial learning and memory functions (<xref ref-type="bibr" rid="B54">54</xref>). A widespread comorbid condition in ASD is anxiety (<xref ref-type="bibr" rid="B71">71</xref>), prompting the evaluation of anxious-like behavior in the HTX-offspring using the EPM test. The HTX-offspring displayed a significant preference for closed spaces over exposed arms (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;1-1.2a-d</bold>
</xref>), mirroring observations in MIA and VPA offspring (<xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B80">80</xref>). These findings suggest a shared pattern of anxiety-related responses among HTX, MIA, and VPA offspring, which are associated with ASD-like manifestations in mice. This resemblance underscores the high prevalence of anxiety as a primary comorbid condition in ASD (<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B80">80</xref>). On the other hand, traits associated with social hierarchy, including aggressive and submissive behaviors, are widely addressed in neurodevelopmental disorders research (<xref ref-type="bibr" rid="B61">61</xref>). To assess these behaviors, the tube dominance test was conducted, revealing that HTX-offspring displayed subordinate behavior in comparison to Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;1-1.3a-c</bold>
</xref>). The behavioral patterns exhibited by HTX-offspring in this regard bore resemblance to those observed in genetically modified mouse models of ASD, such as SHANK2 and SHANK3 mutant mice (<xref ref-type="bibr" rid="B81">81</xref>). These convergences in behavior raise the possibility that&#xa0;HTX exposure may affect the expression of genes related to prenatal ASD development, potentially affecting the normal neurodevelopment (<xref ref-type="bibr" rid="B81">81</xref>). Finally, the three-chamber social preference test was conducted to assess social interaction preferences, crucial in ASD diagnosis (<xref ref-type="bibr" rid="B62">62</xref>). The male HTX-offspring exhibited a significantly increased preference for inanimate objects over social stimuli, maintaining this lack of interest until the introduction of a novel social stimulus (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;1-1.4</bold>
</xref>a-l). While the females also interacted for less time with the social stimulus, they did not show greater interest in the nonsocial stimulus, suggesting overall sex-dependent ASD-like behavioral manifestations in the HTX-offspring. Notably, the HTX-offspring, regardless of sex, showed extended interaction with the first social stimulus compared to the new one (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;1-1.4a-l</bold>
</xref>). These trends were concordant with previous observations in different ASD-like models, including MIA and VPA offspring, where males tend to manifest more pronounced deficits in social interaction abilities (<xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B83">83</xref>). In the context of the three-chamber test, these results are indicators of impaired social skills, which are widely recognized to correlate with recurring ASD-like behaviors in both humans and mice (<xref ref-type="bibr" rid="B84">84</xref>&#x2013;<xref ref-type="bibr" rid="B86">86</xref>).</p>
<p>The behavioral manifestations observed in the HTX-offspring can be associated with ASD-like features, thus validating previous retrospective studies in humans. However, it&#x2019;s important to note that the conclusions drawn from this work regarding behavior are limited to the tests described here. Hence, this study opens the possibility of conducting a more exhaustive behavioral analysis to evaluate other ASD-like behavioral facets comprehensively.</p>
<p>Transitioning into the molecular analyses, ASD has an immune component mainly featured by increased concentration of proinflammatory cytokines in blood samples of patients (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Female and male HTX-offspring displayed elevated levels of IL-6, IL-17A, IL-1&#x3b2;, and TNF-&#x3b1; in their blood compared to Control and HTX+T<sub>4</sub> offspring (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A-D</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;2-2.1a-d</bold>
</xref>). Conversely, there was a decrease in the levels of the anti-inflammatory cytokine IL-10, but this effect was specific to male HTX-offspring (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6E</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2-2.1e</bold>
</xref>). These findings align with research reported in children diagnosed with ASD (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>), suggesting that this alteration may potentially serve as a hallmark of ASD disorders, considering its significant prevalence among diagnosed individuals (<xref ref-type="bibr" rid="B87">87</xref>&#x2013;<xref ref-type="bibr" rid="B89">89</xref>). Interestingly, at the molecular level, IFN-&#x3b3; and IL-1&#x3b2; have recently been discovered to stimulate GABAergic neurons, resulting in hyper-connectivity in fronto-cortical brain regions and subsequent impairments in social and anxious behaviors (<xref ref-type="bibr" rid="B90">90</xref>). Furthermore, the same study reports a strong statistical correlation between increased levels of IFN-&#x3b3; and IL-1&#x3b2; and alterations in social behaviors not only in mice but also in&#xa0;fish and flies (<xref ref-type="bibr" rid="B90">90</xref>). The proinflammatory status observed in the&#xa0;HTX-offspring leads us to speculate that the elevated proinflammatory cytokines may affect neuronal functions, potentially translating into the observed ASD-like behavioral alterations in sociability and anxiety. With this in mind, we also infer that the increased concentration of IL-1&#x3b2; in the blood of male HTX-offspring compared to female HTX-offspring might be associated with the heightened interest of males in direct interact with the nonsocial stimuli in the three-chamber social test (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). The rationale behind these associations is justified by the fact that as the HTX-offspring exhibit an elevated concentration of IL-1&#x3b2; in the blood (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>), there is a corresponding decrease in the number of buried marbles, the number of entrances to the open arms, the time of direct interaction with the nonsocial stimuli, and more time interacting with the Stranger 1 stimuli (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>). These alterations further support the notion that heightened levels of proinflammatory cytokines in the HTX-offspring could impact their behavior and potentiate their proinflammatory status.</p>    <p>Neuroinflammation, triggered by the local increase in brain regions of IL-17A, is a significant feature in ASD pathophysiology (<xref ref-type="bibr" rid="B91">91</xref>). The levels of IL-17A in both the PFC and hippocampus of HTX-offspring were notably higher compared to those in the Control and HTX+T<sub>4</sub> offspring of both sexes (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7A, C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;2-2.2a, c</bold>
</xref>). This observation is consistent with previous research showing that MIA-offspring exhibited increased proinflammatory cytokines like IL-17A, TNF-&#x3b1;, IL-1&#x3b2;, and IL-6, accompanied by synaptic deficiencies in the PFC and increased Iba1 mark in astrocytes of brain cortex and cerebellum (<xref ref-type="bibr" rid="B92">92</xref>&#x2013;<xref ref-type="bibr" rid="B95">95</xref>). Similar trends have been observed in the VPA-offspring, where also microglial activation and structural changes were apparent in specific brain regions like the PFC and hippocampus (<xref ref-type="bibr" rid="B96">96</xref>). Interestingly, a previous study demonstrated that microglia derived from the HTX-gestated offspring exhibited heightened reactivity compared to those from the offspring gestated under euthyroid conditions when exposed to a proinflammatory stimulus (<xref ref-type="bibr" rid="B52">52</xref>). This finding reinforces the notion of the presence of neuroinflammatory-like traits in HTX-offspring, indicating a greater propensity to respond more severely to inflammation (<xref ref-type="bibr" rid="B52">52</xref>). We also identified a reduction in IL-10, but only within the PFC and hippocampus of male HTX-offspring (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7B, D</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;2-2.2b, d</bold>
</xref>). This discovery is consistent with previously reported sex-specific patterns of neuroinflammation, which may potentially contribute to the increased susceptibility of males to neurodevelopmental disorders (<xref ref-type="bibr" rid="B97">97</xref>&#x2013;<xref ref-type="bibr" rid="B99">99</xref>). It has been demonstrated that elevated levels of IL-17A exerts detrimental effects on CNS function (<xref ref-type="bibr" rid="B100">100</xref>). Specifically, neuroinflammation triggers the activation of T-cells, macrophages, microglia, and astrocytes in the brain, resulting in decreased hippocampal neurogenesis through apoptotic pathways, heightened GABAergic signaling, and upregulation of MHC class I and II protein complexes (<xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B100">100</xref>, <xref ref-type="bibr" rid="B101">101</xref>). Additionally, IL-17A induces reduced dendritic spine density and enhances reactive microglial phenotypes (<xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B100">100</xref>, <xref ref-type="bibr" rid="B101">101</xref>). These alterations in the central nervous system (CNS) have been correlated with ASD-like behavioral outcomes, particularly affecting social interactions (<xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B100">100</xref>, <xref ref-type="bibr" rid="B101">101</xref>). Hence, we infer that the increased levels of IL-17A in brain regions related to social cognition of the HTX-gestated offspring (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>) may further contribute to the cognitive impairments evidenced by the performance of these offspring in the marble burying test (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>).</p>
<p>Alterations in immune cell populations have been observed in ASD-like models (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B48">48</xref>). The differences observed on immune cell populations demonstrate an inherent imbalance between tolerogenic and inflammatory T cells in female and male HTX-offspring (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8A-E</bold>
</xref>). This imbalance results from an augmented number of Th17 cells and a decreased Treg cell number, leading to an elevated Th17/Tregs ratio in this offspring (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8A-E</bold>
</xref>). This observation aligns with earlier reports demonstrating that autistic children exhibit a heightened proportion of Th17 cells in comparison to Treg cells (<xref ref-type="bibr" rid="B65">65</xref>). These findings are also consistent with prior reports indicating that adult HTX-offspring exhibit a diminished tolerogenic capacity when confronted with the challenge of experimental autoimmune encephalomyelitis (EAE) (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B102">102</xref>). Complementary, their na&#xef;ve T cells exhibited a reduced inclination to differentiate into the Treg cell phenotype which could be a possible contribution to the diminished Treg cell number observed (<xref ref-type="bibr" rid="B53">53</xref>). Additionally, we detected an increase in the absolute number of M1-like macrophages in HTX-offspring, while the absolute count of M2-like macrophages and NK cells remained consistent across experimental groups and both sexes (<xref ref-type="fig" rid="f9">
<bold>Figures&#xa0;9A-D</bold>
</xref>). Given that M1-like macrophages exhibit a pro-inflammatory profile (<xref ref-type="bibr" rid="B103">103</xref>), this imbalance agrees with the notion of an underlying basal inflammatory state in HTX-offspring.</p>
<p>The results concerning the proinflammatory status of HTX-gestated offspring suggest that elevated levels of specific cytokines may impair neuronal functions in relevant brain regions, thereby contributing to the induction of behavioral and cognitive alterations resembling ASD-like manifestations. Additionally, the proinflammatory state of HTX-offspring appears to reinforce itself, as evidenced by the correlations found between cytokine levels and the mentioned immune cell populations.</p>
<p>Disruptions in glutamatergic protein expression represent another relevant feature associated with ASD disorders (<xref ref-type="bibr" rid="B104">104</xref>, <xref ref-type="bibr" rid="B105">105</xref>). In fact, autism can be conceptualized as a synaptic disorder characterized by an equilibrium disruption between excitatory and inhibitory synapses (<xref ref-type="bibr" rid="B106">106</xref>). Focusing on the glutamatergic synapses, alterations in scaffolding proteins expression have been implicated in the manifestation of autistic traits (<xref ref-type="bibr" rid="B107">107</xref>&#x2013;<xref ref-type="bibr" rid="B109">109</xref>). In this work, we identified an augmented expression of NLGN3 and HOMER1 primarily in the hippocampus of male HTX-offspring (<xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10D, H</bold>
</xref>). It has been documented that an elevated HOMER1 expression has been linked to ASD-like behaviors as well as deficits in fear conditioning (<xref ref-type="bibr" rid="B42">42</xref>). In addition, the expression patterns of these proteins were also region-specific within the brain. For instance, the PFC did not display substantial changes in the expression of NLGN3 or HOMER1 across experimental groups (<xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10B, F</bold>
</xref>). However, a basal elevation in HOMER1 levels was noted in males across all three experimental groups when compared&#xa0;to females (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10F</bold>
</xref>). The mechanisms underlying the sex-dependent expression of these proteins remain elusive. Nonetheless, these intriguing observations could potentially offer valuable insights into unraveling the molecular foundations contributing to the heightened susceptibility of males in developing an ASD-like condition compared to females. Furthermore, it is proposed that neuroinflammation may influence the expression of glutamatergic proteins (<xref ref-type="bibr" rid="B107">107</xref>&#x2013;<xref ref-type="bibr" rid="B109">109</xref>). However, no correlations were found between the levels of NLGN3 or HOMER1 expression and IL-17 or IL-10 in the PFC or hippocampus, nor with the behavioral parameters assessed in this study (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>). This suggests that alterations in hippocampal HOMER1 expression in males are not influenced by IL-17A levels, nor vice versa, and that these alterations are not directly associated with the observed behavioral changes. Nonetheless, further investigation is warranted to elucidate the complex interplay between neuroinflammation and glutamatergic protein expression in the context of ASD-like manifestations in the HTX-gestated offspring.</p>
<p>At the same time that we performed the data analyses by separating them according to sex with the intention of exploring sex-dependent outcomes, we conducted the analyses by combining the female and male data as a single Control, HTX, and HTX+T<sub>4</sub> experimental group (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;5</bold>
</xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1">
<bold>14</bold>
</xref>). In general, we observed similar results when combining the data. However, in terms of the duration of direct interaction with Stranger 1 stimuli (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;9C</bold>
</xref>), TNF-&#x3b1; blood levels (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;10A</bold>
</xref>), and the absolute number of M1-like macrophages in the spleen (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15A</bold>
</xref>), the levels of each parameter in the HTX+T<sub>4</sub>-offspring were statistically lower than those in the HTX-offspring and even the Control-offspring. Another notable difference was found in the expression levels of hippocampal NLGN3 in the HTX+T<sub>4</sub>-offspring, which were not statistically smaller than those in the HTX-offspring as observed in the Control-offspring (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;14B</bold>
</xref>). We attribute these differences to the plausible synergistic effects of T<sub>4</sub> supplementation in mitigating specific behavioral alterations and inflammatory responses in HTX-gestated offspring. Nonetheless, while this suggests a potentially promising avenue for intervention strategies aimed at correcting maternal thyroid hormone deficiency during pregnancy, it also underscores the importance of determining appropriate levels of T<sub>4</sub> supplementation to avoid exacerbated synergistic effects (<xref ref-type="bibr" rid="B110">110</xref>, <xref ref-type="bibr" rid="B111">111</xref>). In this context, we emphasize that this article focuses on a condition that decreases maternal T<sub>4</sub> levels and evaluates its effects on the offspring. Therefore, we did not consider treatment solely with T<sub>4</sub>, as elevated maternal T<sub>4</sub> levels may induce transient non-autoimmune forms of hyperthyroidism characterized by an increase in T<sub>4</sub> levels with almost undetectable TSH (<xref ref-type="bibr" rid="B112">112</xref>). Even so, gestational hyperthyroidism is more related to increased risk of preeclampsia, preterm delivery, heart failure, and thyroid storm in the mother, and to low birth weight, intrauterine growth retardation, and in the fetus (<xref ref-type="bibr" rid="B112">112</xref>). On the other hand, the blood levels of IL-10 are reduced in the HTX-offspring (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;10E</bold>
</xref>), but when we separate the data according to sex, we observed that this difference is due to the male HTX-offspring (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6E</bold>
</xref>). Similarly, the levels of IL-10 in the PFC of the HTX-offspring tend to be decreased compared to Control-offspring (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;11B</bold>
</xref>), nonetheless, when we separate the data according to sex, we observed that only male HTX-offspring has reduced levels of IL-10 in the PFC (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). The expression levels of HOMER1 in both the prefrontal cortex (PFC) and hippocampus of HTX offspring did not show statistical differences when compared to those of the Control and HTX+T<sub>4</sub> offspring (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;14C, D</bold>
</xref>). However, had we not separated the data according to sex, it would not have been possible to identify that only males exhibited an increased expression levels of HOMER1 in the PFC and hippocampus (<xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10E-H</bold>
</xref>). In summary, through this study, we suggest the need to analyze ASD-like outcomes ideally by separating the data according to sex, as this concise modification in data analysis can unveil interesting perspectives on ASD-like manifestations.</p>
<p>Since our experimental design involved evaluating ASD-like phenotypes in mice gestated under HTX, and we contemplated using mice from the different litters (mitigating the impact of the litter effect (<xref ref-type="bibr" rid="B69">69</xref>)), we were able to conduct a correlation analysis between maternal T<sub>4</sub> levels and the ASD-like outcomes in the offspring (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). Notably, we identified a positive association between maternal T<sub>4</sub> levels and specific behavioral parameters, alongside elevated serum IL-10 levels. Conversely, an inverse relationship was observed between maternal T<sub>4</sub> levels and proinflammatory cytokines in serum (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). Moreover, our analysis revealed associations among autism-like outcomes, showing that behavioral alterations correlated with proinflammatory traits, and these proinflammatory markers were interrelated (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;15</bold>
</xref>). These findings align with previous reports indicating correlations between prenatal inducers of ASD such as maternal inflammation, VPA treatment, exposure to teratogens or contaminants, and nutritional deficiencies with ASD-like alterations in behaviors, increased proinflammatory markers, and abnormal expression of glutamatergic proteins in the offspring (<xref ref-type="bibr" rid="B113">113</xref>&#x2013;<xref ref-type="bibr" rid="B118">118</xref>). Therefore, this study provides compelling insights into the potential influence of maternal T<sub>4</sub> on distinct ASD-like phenotypes in the offspring.</p>
<p>Prenatal inducers of ASD-like phenotypes in the offspring must occur within a specific timeframe (early embryonic days (E10-E12.5 or E14)) (<xref ref-type="bibr" rid="B113">113</xref>&#x2013;<xref ref-type="bibr" rid="B118">118</xref>). Regarding gestational HTX, this specific timeframe is chosen because during this period of gestation maternal T<sub>4</sub> plays an active and crucial role in the proper neurodevelopment of the fetus, closely resembling early human gestation (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B120">120</xref>). The mechanisms underlying how gestational HTX heightens the risk of ASD in the offspring remain unknown. Curiously, maternal autoimmune disorders affecting the thyroid gland have also been identified as risk factors for ASD-like traits in the offspring (<xref ref-type="bibr" rid="B121">121</xref>). Specifically, offspring gestated in mothers afflicted with Hashimoto&#x2019;s thyroiditis with elevated thyroid peroxidase antibody (TPO-Ab<sup>+</sup>) levels were found to have approximately an 80% increased probability of developing autistic traits (<xref ref-type="bibr" rid="B121">121</xref>). Consequently, thyroid disorders during early pregnancy may trigger proinflammatory responses, potentially leading to morphological and epigenetic changes in fetal neurodevelopment (<xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B123">123</xref>). This could increase the likelihood of ASD-like traits in the offspring, similar to findings MIA model (<xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B123">123</xref>). Thus, we believe that gestational HTX could induce such ASD-like traits by inducing a maternal proinflammatory response, underscoring the intricate interplay between maternal THs and inflammation during fetal programming associated with neurodevelopmental disorders.</p>
<p>Overall, this research represents the first validation of a causal link between gestational HTX and ASD-like phenotypes in the offspring of both sexes&#x2014;a phenomenon that is mitigated by T<sub>4</sub> restoration during pregnancy. Furthermore, our associative findings suggest that the proinflammatory status of the HTX-offspring may influence their behavior through alterations in neuroinflammatory responses and glutamatergic protein expression. These insights underscore the complex interplay between maternal thyroid function, immune regulation, and neurodevelopmental outcomes in the offspring. Moving forward, elucidating the underlying mechanisms linking gestational HTX, neuroinflammation, and ASD-like phenotypes holds promise for informing preventive and therapeutic strategies for individuals at risk of neurodevelopmental disorders. Further investigations into the molecular pathways involved in these processes will be crucial for advancing our understanding and developing targeted interventions to mitigate the impact of gestational thyroid dysfunction on the offspring neurodevelopment.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>This study provides groundbreaking evidence demonstrating that gestational HTX significantly increases the likelihood of developing ASD-like phenotypes in the offspring. Behaviorally, the HTX-exposed offspring of both sexes exhibited compromised neurocognitive functions, heightened anxious-like behaviors, reduced aggressive behavior, and a pronounced preference for interacting with inanimate stimuli over other mice. These behavioral alterations were accompanied by molecular impairments, including inflammation and altered expression of glutamatergic proteins, particularly in male offspring. Furthermore, maternal T<sub>4</sub> levels were found to be associated with specific behavioral and proinflammatory ASD-like outcomes in the offspring, underscoring the pivotal role of maternal thyroid hormones in neurodevelopmental disorders such as ASD. Importantly, these findings shed light on sex-dependent factors contributing to vulnerability to neurodevelopmental disorders and underscore the importance of closely monitoring thyroid function during early pregnancy.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by Animal Welfare Committee of the Facultad de Ciencias de la Vida (Universidad Andr&#xe9;s Bello) (Bioethics approval certificate number 012/2021). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>EG-M: Conceptualization, Data curation, Investigation, Methodology, Software, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. MR-R: Investigation, Methodology, Software, Writing &#x2013; review &amp; editing. MO: Data curation, Formal analysis, Methodology, Supervision, Validation, Writing &#x2013; review &amp; editing. LM: Investigation, Methodology, Software, Writing &#x2013; review &amp; editing. KB: Formal analysis, Methodology, Supervision, Writing &#x2013; review &amp; editing. SB: Formal analysis, Validation, Writing &#x2013; review &amp; editing, Funding acquisition. PG: Formal analysis, Validation, Writing &#x2013; review &amp; editing. AK: Formal analysis, Validation, Writing &#x2013; review &amp; editing, Funding acquisition. CR: Formal analysis, Funding acquisition, Supervision, Validation, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by the Millennium Institute on Immunology and Immunotherapy PROGRAMA ICM - ANID, ICN2021_045; FONDECYT #1191300, #1231905, #1231851, and #11221280. PG is supported by FONDECYT grant 1240971 and UC grant PUENTE-2023-18. EG-M thanks to ANID for providing a Ph.D. Scholarship (21202085).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank LM for all administrative and technical support in performing this work and the Millennium Institute on Immunology and Immunotherapy (IMII) for support.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors&#xa0;and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2024.1381180/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2024.1381180/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>ADHD, attention-deficit disorder; ASD, Autism spectrum disorder; HOMER1, Homer protein homolog 1; HTX, hypothyroxinemia; IL, interleukin-1&#x3b2;, 6, 17A, 10; IQ, intelligence quotient; MMI, 2-mercapto-1-methylimidazole or methimazole; NKs, Natural killer cells; NLGN3, Neuroligin 3; PFC, prefrontal cortex; PMA, phorbol myristate acetate; RIPA buffer, Radioimmunoprecipitation assay buffer; RPMI 1640, Roswell Park Memorial Institute 1640 medium; T<sub>3</sub>, 3,5,3&#xa8;-L-tri-iodothyronine; T<sub>4</sub>, 3,5,3&#xa8;5&#xa8;-L-tetra-do-thyronine or thyroxine; TH, thyroid hormones; Treg, T regulatory; TSH. Thyroid-stimulating hormone; TNF-&#x3b1;, Tumor necrosis factor alpha; Th17, T&#xa0;helper 17.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mondal</surname> <given-names>S</given-names>
</name>
<name>
<surname>Raja</surname> <given-names>K</given-names>
</name>
<name>
<surname>Schweizer</surname> <given-names>U</given-names>
</name>
<name>
<surname>Mugesh</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Chemistry and biology in the biosynthesis and action of thyroid hormones</article-title>. <source>Angewandte Chemie Int Ed</source>. (<year>2016</year>) <volume>55</volume>:<page-range>7606&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/anie.201601116</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernal</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Thyroid hormone receptors in brain development and function</article-title>. <source>Nat Clin Pract Endoc</source>. (<year>2007</year>) <volume>3</volume>:<page-range>249&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncpendmet0424</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Meima</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Peeters</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Visser</surname> <given-names>WE</given-names>
</name>
</person-group>. <article-title>Thyroid hormone transporters in pregnancy and fetal development</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<elocation-id>15113</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms232315113</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prezioso</surname> <given-names>G</given-names>
</name>
<name>
<surname>Giannini</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chiarelli</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Effect of thyroid hormones on neurons and neurodevelopment</article-title>. <source>Horm Res Paediat</source>. (<year>2018</year>) <volume>90</volume>:<fpage>73</fpage>&#x2013;<lpage>81</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000492129</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pearce</surname> <given-names>EN</given-names>
</name>
</person-group>. <article-title>Effects of iodine deficiency in pregnancy</article-title>. <source>J Trace Elem Med Bio</source>. (<year>2012</year>) <volume>26</volume>:<page-range>131&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jtemb.2012.04.005</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Vasilopoulou</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kilby</surname> <given-names>MD</given-names>
</name>
</person-group>. <article-title>The role of the placenta in thyroid hormone delivery to the fetus</article-title>. <source>Nat Clin Pr Endocrinol Metab</source>. (<year>2009</year>) <volume>5</volume>:<fpage>45</fpage>&#x2013;<lpage>54</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncpendmet1026</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahadik</surname> <given-names>K</given-names>
</name>
<name>
<surname>Choudhary</surname> <given-names>P</given-names>
</name>
<name>
<surname>Roy</surname> <given-names>PK</given-names>
</name>
</person-group>. <article-title>Study of thyroid function in pregnancy, its feto-maternal outcome; a prospective observational study</article-title>. <source>BMC Pregnancy Childbirth</source>. (<year>2020</year>) <volume>20</volume>:<fpage>769</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12884-020-03448-z</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xf3;pez-Mu&#xf1;oz</surname> <given-names>E</given-names>
</name>
<name>
<surname>Mateos-S&#xe1;nchez</surname> <given-names>L</given-names>
</name>
<name>
<surname>Mej&#xed;a-Terrazas</surname> <given-names>GE</given-names>
</name>
<name>
<surname>Bedwell-Cordero</surname> <given-names>SE</given-names>
</name>
</person-group>. <article-title>Hypothyroidism and isolated hypothyroxinemia in pregnancy, from physiology to the clinic</article-title>. <source>Taiwan J Obstet Gynecol</source>. (<year>2019</year>) <volume>58</volume>:<page-range>757&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tjog.2019.09.005</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calvo</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Jauniaux</surname> <given-names>E</given-names>
</name>
<name>
<surname>Gulbis</surname> <given-names>B</given-names>
</name>
<name>
<surname>Asunci&#xf3;n</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gervy</surname> <given-names>C</given-names>
</name>
<name>
<surname>Contempr&#xe9;</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2002</year>) <volume>87</volume>:<page-range>1768&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jcem.87.4.8434</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Negro</surname> <given-names>R</given-names>
</name>
<name>
<surname>Soldin</surname> <given-names>OP</given-names>
</name>
<name>
<surname>Obregon</surname> <given-names>M-J</given-names>
</name>
<name>
<surname>Stagnaro-Green</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Hypothyroxinemia and pregnancy</article-title>. <source>Endocr Pract</source>. (<year>2011</year>) <volume>17</volume>:<page-range>422&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4158/EP10309.RA</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>The impact of gestational hypothyroxinemia on the cognitive and motor development of offspring</article-title>. <source>J Maternal-Fetal Neonatal Med</source>. (<year>2018</year>) <volume>33</volume>:<fpage>1</fpage>&#x2013;<lpage>6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14767058.2018.1529749</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levie</surname> <given-names>D</given-names>
</name>
<name>
<surname>Korevaar</surname> <given-names>TIM</given-names>
</name>
<name>
<surname>Bath</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Dalmau-Bueno</surname> <given-names>A</given-names>
</name>
<name>
<surname>Murcia</surname> <given-names>M</given-names>
</name>
<name>
<surname>Espada</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Thyroid function in early pregnancy, child IQ, and autistic traits: A meta-analysis of individual participant data</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2018</year>) <volume>103</volume>:<page-range>2967&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jc.2018-00224</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>W</given-names>
</name>
<name>
<surname>Song</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>J</given-names>
</name>
<name>
<surname>Min</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Developmental hypothyroxinemia caused by mild iodine deficiency leads to HFS-induced LTD in rat hippocampal CA1 region: involvement of AMPA receptor</article-title>. <source>Mol Neurobiol</source>. (<year>2014</year>) <volume>50</volume>:<page-range>348&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12035-014-8656-2</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Min</surname> <given-names>H</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Teng</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xi</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal hypothyroxinemia-induced neurodevelopmental impairments in the progeny</article-title>. <source>Mol Neurobiol</source>. (<year>2016</year>) <volume>53</volume>:<page-range>1613&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12035-015-9101-x</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Maternal thyroxine levels during pregnancy and outcomes of cognitive development in children</article-title>. <source>Mol Neurobiol</source>. (<year>2016</year>) <volume>53</volume>:<page-range>2241&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12035-015-9189-z</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Modesto</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tiemeier</surname> <given-names>H</given-names>
</name>
<name>
<surname>Peeters</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Jaddoe</surname> <given-names>VWV</given-names>
</name>
<name>
<surname>Hofman</surname> <given-names>A</given-names>
</name>
<name>
<surname>Verhulst</surname> <given-names>FC</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal mild thyroid hormone insufficiency in early pregnancy and attention-deficit/hyperactivity disorder symptoms in children</article-title>. <source>JAMA Pediatr</source>. (<year>2015</year>) <volume>169</volume>:<page-range>838&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jamapediatrics.2015.0498</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersen</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Andersen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Vestergaard</surname> <given-names>P</given-names>
</name>
<name>
<surname>Olsen</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Maternal thyroid function in early pregnancy and child neurodevelopmental disorders: A danish nationwide case-cohort study</article-title>. <source>Thyroid</source>. (<year>2018</year>) <volume>28</volume>:<page-range>537&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2017.0425</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rom&#xe1;n</surname> <given-names>GC</given-names>
</name>
<name>
<surname>Ghassabian</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bongers-Schokking</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Jaddoe</surname> <given-names>VWV</given-names>
</name>
<name>
<surname>Hofman</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rijke</surname> <given-names>YB</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of gestational maternal hypothyroxinemia and increased autism risk</article-title>. <source>Ann Neurol</source>. (<year>2013</year>) <volume>74</volume>:<page-range>733&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ana.23976</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Association</surname> <given-names>AP</given-names>
</name>
</person-group>. <article-title>Diagnostic and statistical manual of mental disorders, DSM-5</article-title>. (<year>2013</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1176/appi.books.9780890425596</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeidan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fombonne</surname> <given-names>E</given-names>
</name>
<name>
<surname>Scorah</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ibrahim</surname> <given-names>A</given-names>
</name>
<name>
<surname>Durkin</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Saxena</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Global prevalence of autism: A systematic review update</article-title>. <source>Autism Res</source>. (<year>2022</year>) <volume>15</volume>:<page-range>778&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/aur.2696</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheroni</surname> <given-names>C</given-names>
</name>
<name>
<surname>Caporale</surname> <given-names>N</given-names>
</name>
<name>
<surname>Testa</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology</article-title>. <source>Mol Autism</source>. (<year>2020</year>) <volume>11</volume>:<fpage>69</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13229-020-00370-1</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Persico</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Merelli</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Environmental factors in the onset of autism spectrum disorder</article-title>. <source>Curr Dev Disord Rep</source>. (<year>2014</year>) <volume>1</volume>:<fpage>8</fpage>&#x2013;<lpage>19</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40474-013-0002-2</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pugsley</surname> <given-names>K</given-names>
</name>
<name>
<surname>Scherer</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Bellgrove</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Hawi</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Environmental exposures associated with elevated risk for autism spectrum disorder may augment the burden of deleterious <italic>de novo</italic> mutations among probands</article-title>. <source>Mol Psychiatry</source>. (<year>2022</year>) <volume>27</volume>:<page-range>710&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41380-021-01142-w</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rylaarsdam</surname> <given-names>L</given-names>
</name>
<name>
<surname>Guemez-Gamboa</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Genetic causes and modifiers of autism spectrum disorder</article-title>. <source>Front Cell Neurosci</source>. (<year>2019</year>) <volume>13</volume>:<elocation-id>385</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fncel.2019.00385</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carter</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Rahman</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Shu</surname> <given-names>Y-H</given-names>
</name>
<name>
<surname>Chow</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>
<italic>In utero</italic> exposure to near-roadway air pollution and autism spectrum disorder in children</article-title>. <source>Environ Int</source>. (<year>2022</year>) <volume>158</volume>:<elocation-id>106898</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.envint.2021.106898</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flanagan</surname> <given-names>E</given-names>
</name>
<name>
<surname>Malmqvist</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rittner</surname> <given-names>R</given-names>
</name>
<name>
<surname>Gustafsson</surname> <given-names>P</given-names>
</name>
<name>
<surname>K&#xe4;ll&#xe9;n</surname> <given-names>K</given-names>
</name>
<name>
<surname>Oudin</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Exposure to local, source-specific ambient air pollution during pregnancy and autism in children: a cohort study from southern Sweden</article-title>. <source>Sci Rep</source>. (<year>2023</year>) <volume>13</volume>:<fpage>3848</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-023-30877-5</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahman</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Shu</surname> <given-names>Y-H</given-names>
</name>
<name>
<surname>Chow</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lurmann</surname> <given-names>FW</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>MP</given-names>
</name>
<etal/>
</person-group>. <article-title>Prenatal exposure to air pollution and autism spectrum disorder: sensitive windows of exposure and sex differences</article-title>. <source>Environ Heal Perspect</source>. (<year>2022</year>) <volume>130</volume>:<fpage>017008</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1289/ehp9509</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alfageh</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Man</surname> <given-names>KKC</given-names>
</name>
<name>
<surname>Besag</surname> <given-names>FMC</given-names>
</name>
<name>
<surname>Alhawassi</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>ICK</given-names>
</name>
<name>
<surname>Brauer</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Psychotropic medication prescribing for neuropsychiatric comorbidities in individuals diagnosed with autism spectrum disorder (ASD) in the UK</article-title>. <source>J Autism Dev Disord</source>. (<year>2020</year>) <volume>50</volume>:<page-range>625&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10803-019-04291-8</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schiavi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Iezzi</surname> <given-names>D</given-names>
</name>
<name>
<surname>Manduca</surname> <given-names>A</given-names>
</name>
<name>
<surname>Leone</surname> <given-names>S</given-names>
</name>
<name>
<surname>Melancia</surname> <given-names>F</given-names>
</name>
<name>
<surname>Carbone</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Reward-related behavioral, neurochemical and electrophysiological changes in a rat model of autism based on prenatal exposure to valproic acid</article-title>. <source>Front Cell Neurosci</source>. (<year>2019</year>) <volume>13</volume>:<elocation-id>479</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fncel.2019.00479</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyall</surname> <given-names>K</given-names>
</name>
<name>
<surname>Song</surname> <given-names>L</given-names>
</name>
<name>
<surname>Botteron</surname> <given-names>K</given-names>
</name>
<name>
<surname>Croen</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Dager</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Fallin</surname> <given-names>MD</given-names>
</name>
<etal/>
</person-group>. <article-title>The association between parental age and autism-related outcomes in children at high familial risk for autism</article-title>. <source>Autism Res</source>. (<year>2020</year>) <volume>13</volume>:<fpage>998</fpage>&#x2013;<lpage>1010</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/aur.2303</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brynge</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sj&#xf6;qvist</surname> <given-names>H</given-names>
</name>
<name>
<surname>Gardner</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>BK</given-names>
</name>
<name>
<surname>Dalman</surname> <given-names>C</given-names>
</name>
<name>
<surname>Karlsson</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Maternal infection during pregnancy and likelihood of autism and intellectual disability in children in Sweden: a negative control and sibling comparison cohort study</article-title>. <source>Lancet Psychiatry</source>. (<year>2022</year>) <volume>9</volume>:<page-range>782&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s2215-0366(22)00264-4</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: A systematic review and meta-analysis</article-title>. <source>Behav Brain Res</source>. (<year>2016</year>) <volume>296</volume>:<page-range>61&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbr.2015.08.035</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname> <given-names>ZB</given-names>
</name>
<name>
<surname>Pearce</surname> <given-names>EN</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>H-M</given-names>
</name>
<name>
<surname>Schmidt</surname> <given-names>RJ</given-names>
</name>
</person-group>. <article-title>Maternal thyroid dysfunction during pregnancy as an etiologic factor in autism spectrum disorder: challenges and opportunities for research</article-title>. <source>Thyroid</source>. (<year>2024</year>) <volume>34</volume>:<page-range>144&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2023.0391</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melancia</surname> <given-names>F</given-names>
</name>
<name>
<surname>Servadio</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schiavi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Campolongo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Giusti-Paiva</surname> <given-names>A</given-names>
</name>
<name>
<surname>Trezza</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Testing the correlation between experimentally-induced hypothyroidism during pregnancy and autistic-like symptoms in the rat offspring</article-title>. <source>Behav Brain Res</source>. (<year>2017</year>) <volume>321</volume>:<page-range>113&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbr.2016.12.032</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname> <given-names>A</given-names>
</name>
<name>
<surname>Geschwind</surname> <given-names>DH</given-names>
</name>
</person-group>. <article-title>Human <italic>in vitro</italic> models for understanding mechanisms of autism spectrum disorder</article-title>. <source>Mol Autism</source>. (<year>2020</year>) <volume>11</volume>:<fpage>26</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13229-020-00332-7</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverman</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lord</surname> <given-names>C</given-names>
</name>
<name>
<surname>Crawley</surname> <given-names>JN</given-names>
</name>
</person-group>. <article-title>Behavioural phenotyping assays for mouse models of autism</article-title>. <source>Nat Rev Neurosci</source>. (<year>2010</year>) <volume>11</volume>:<fpage>490</fpage>&#x2013;<lpage>502</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrn2851</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverman</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Thurm</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ethridge</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Soller</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Petkova</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Abel</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Reconsidering animal models used to study autism spectrum disorder: Current state and optimizing future</article-title>. <source>Genes Brain Behav</source>. (<year>2022</year>) <volume>21</volume>:<fpage>e12803</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/gbb.12803</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masi</surname> <given-names>A</given-names>
</name>
<name>
<surname>DeMayo</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Glozier</surname> <given-names>N</given-names>
</name>
<name>
<surname>Guastella</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>An overview of autism spectrum disorder, heterogeneity and treatment options</article-title>. <source>Neurosci Bull</source>. (<year>2017</year>) <volume>33</volume>:<page-range>183&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12264-017-0100-y</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crawley</surname> <given-names>JN</given-names>
</name>
</person-group>. <article-title>Translational animal models of autism and neurodevelopmental disorders</article-title>. <source>Dialogues Clin Neurosci</source>. (<year>2012</year>) <volume>14</volume>:<fpage>293</fpage>&#x2013;<lpage>305</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.31887/DCNS.2012.14.3/jcrawley</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nisar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bhat</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Masoodi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hashem</surname> <given-names>S</given-names>
</name>
<name>
<surname>Akhtar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>TA</given-names>
</name>
<etal/>
</person-group>. <article-title>Genetics of glutamate and its receptors in autism spectrum disorder</article-title>. <source>Mol Psychiatry</source>. (<year>2022</year>) <volume>27</volume>:<page-range>2380&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41380-022-01506-w</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sigurdsson</surname> <given-names>T</given-names>
</name>
<name>
<surname>Duvarci</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Hippocampal-prefrontal interactions in cognition, behavior and psychiatric disease</article-title>. <source>Front Syst Neurosci</source>. (<year>2016</year>) <volume>9</volume>:<elocation-id>190</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnsys.2015.00190</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname> <given-names>A</given-names>
</name>
<name>
<surname>Luong</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>A</given-names>
</name>
<name>
<surname>Saib</surname> <given-names>AO</given-names>
</name>
<name>
<surname>Ploski</surname> <given-names>JE</given-names>
</name>
</person-group>. <article-title>Overexpression of Homer1a in the basal and lateral amygdala impairs fear conditioning and induces an autism-like social impairment</article-title>. <source>Mol Autism</source>. (<year>2016</year>) <volume>7</volume>:<elocation-id>16</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13229-016-0077-9</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname> <given-names>ESK</given-names>
</name>
<name>
<surname>Nakayama</surname> <given-names>H</given-names>
</name>
<name>
<surname>Miyazaki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Nakazawa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tabuchi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hashimoto</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>An autism-associated neuroligin-3 mutation affects developmental synapse elimination in the cerebellum</article-title>. <source>Front Neural Circuits</source>. (<year>2021</year>) <volume>15</volume>:<elocation-id>676891</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fncir.2021.676891</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uchigashima</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>A</given-names>
</name>
<name>
<surname>Futai</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Neuroligin-3: A circuit-specific synapse organizer that shapes normal function and autism spectrum disorder-associated dysfunction</article-title>. <source>Front Mol Neurosci</source>. (<year>2021</year>) <volume>14</volume>:<elocation-id>749164</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnmol.2021.749164</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Glozier</surname> <given-names>N</given-names>
</name>
<name>
<surname>Dale</surname> <given-names>R</given-names>
</name>
<name>
<surname>Guastella</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>The immune system, cytokines, and biomarkers in autism spectrum disorder</article-title>. <source>Neurosci Bull</source>. (<year>2017</year>) <volume>33</volume>:<fpage>194</fpage>&#x2013;<lpage>204</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12264-017-0103-8</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meltzer</surname> <given-names>A</given-names>
</name>
<name>
<surname>de Water</surname> <given-names>JV</given-names>
</name>
</person-group>. <article-title>The role of the immune system in autism spectrum disorder</article-title>. <source>Neuropsychopharmacology</source>. (<year>2017</year>) <volume>42</volume>:<page-range>284&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/npp.2016.158</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thawley</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Veneziani</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Rabelo-da-Ponte</surname> <given-names>FD</given-names>
</name>
<name>
<surname>Riederer</surname> <given-names>I</given-names>
</name>
<name>
<surname>Mendes-da-Cruz</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Bambini-Junior</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Aberrant IL-17 levels in rodent models of autism spectrum disorder: A systematic review</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>874064</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.874064</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uddin</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Manley</surname> <given-names>K</given-names>
</name>
<name>
<surname>Lawrence</surname> <given-names>DA</given-names>
</name>
</person-group>. <article-title>Development, phenotypes of immune cells in BTBR T+Itpr3tf/J mice</article-title>. <source>Cell Immunol</source>. (<year>2020</year>) <volume>358</volume>:<elocation-id>104223</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cellimm.2020.104223</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname> <given-names>EY</given-names>
</name>
<name>
<surname>Patterson</surname> <given-names>PH</given-names>
</name>
</person-group>. <article-title>Activation of the maternal immune system induces endocrine changes in the placenta via IL-6</article-title>. <source>Brain Behav Immun</source>. (<year>2011</year>) <volume>25</volume>:<page-range>604&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbi.2010.12.017</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname> <given-names>EY</given-names>
</name>
<name>
<surname>McBride</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Chow</surname> <given-names>J</given-names>
</name>
<name>
<surname>Mazmanian</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Patterson</surname> <given-names>PH</given-names>
</name>
</person-group>. <article-title>Modeling an autism risk factor in mice leads to permanent immune dysregulation</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2012</year>) <volume>109</volume>:<page-range>12776&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1202556109</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guidelines</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>AVMA guidelines for the euthanasia of animals: 2020 edition*</article-title>. <source>J Am Vet Med Assoc (1972)</source>. (<year>2020</year>) <volume>160</volume>:<page-range>761&#x2013;72</page-range>.</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opazo</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Flores</surname> <given-names>BD</given-names>
</name>
<name>
<surname>Venegas</surname> <given-names>LF</given-names>
</name>
<name>
<surname>Albornoz</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Cisternas</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Gestational hypothyroxinemia imprints a switch in the capacity of astrocytes and microglial cells of the offspring to react in inflammation</article-title>. <source>Mol Neurobiol</source>. (<year>2018</year>) <volume>55</volume>:<page-range>4373&#x2013;87</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12035-017-0627-y</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haensgen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Albornoz</surname> <given-names>E</given-names>
</name>
<name>
<surname>Opazo</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Bugue&#xf1;o</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez</surname> <given-names>ELJ</given-names>
</name>
<name>
<surname>Binzberger</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Gestational hypothyroxinemia affects its offspring with a reduced suppressive capacity impairing the outcome of the experimental autoimmune encephalomyelitis</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>:<elocation-id>1257</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.01257</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opazo</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Gianini</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pancetti</surname> <given-names>F</given-names>
</name>
<name>
<surname>Azkcona</surname> <given-names>G</given-names>
</name>
<name>
<surname>Alarc&#xf3;n</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lizana</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal hypothyroxinemia impairs spatial learning and synaptic nature and function in the offspring</article-title>. <source>Endocrinology</source>. (<year>2008</year>) <volume>149</volume>:<page-range>5097&#x2013;106</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2008-0560</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cisternas</surname> <given-names>P</given-names>
</name>
<name>
<surname>Louveau</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bueno</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Kalergis</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Boudin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Riedel</surname> <given-names>CA</given-names>
</name>
</person-group>. <article-title>Gestational hypothyroxinemia affects glutamatergic synaptic protein distribution and neuronal plasticity through neuron-astrocyte interplay</article-title>. <source>Mol Neurobiol</source>. (<year>2016</year>) <volume>53</volume>:<page-range>7158&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12035-015-9609-0</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tartaglione</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Villani</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ajmone-Cat</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Minghetti</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ricceri</surname> <given-names>L</given-names>
</name>
<name>
<surname>Pazienza</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal immune activation induces autism-like changes in behavior, neuroinflammatory profile and gut microbiota in mouse offspring of both sexes</article-title>. <source>Transl Psychiatry</source>. (<year>2022</year>) <volume>12</volume>:<fpage>384</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41398-022-02149-9</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wicke</surname> <given-names>K</given-names>
</name>
<name>
<surname>Gross</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Marble burying behavior is prevented by anxiolytics as well as by motorstimulants</article-title>. <source>Pharmacopsychiatry</source>. (<year>2005</year>) <volume>38</volume>:<fpage>A253</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/s-2005-918875</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angoa-P&#xe9;rez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kane</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Briggs</surname> <given-names>DI</given-names>
</name>
<name>
<surname>Francescutti</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Kuhn</surname> <given-names>DM</given-names>
</name>
</person-group>. <article-title>Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice</article-title>. <source>J Vis Exp</source>. (<year>2013</year>) <volume>82</volume>:<elocation-id>e50978</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3791/50978-v</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walf</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Frye</surname> <given-names>CA</given-names>
</name>
</person-group>. <article-title>Mood and anxiety related phenotypes in mice, characterization using behavioral tests</article-title>. <source>Neuromethods</source>. (<year>2009</year>) <volume>2009</volume>:<page-range>225&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-60761-303-9_12</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walf</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Frye</surname> <given-names>CA</given-names>
</name>
</person-group>. <article-title>The use of the elevated plus maze as an assay of anxiety-related behavior in rodents</article-title>. <source>Nat Protoc</source>. (<year>2007</year>) <volume>2</volume>:<page-range>322&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nprot.2007.44</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>T</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Using the tube test to measure social hierarchy in mice</article-title>. <source>Nat Protoc</source>. (<year>2019</year>) <volume>14</volume>:<page-range>819&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41596-018-0116-4</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rein</surname> <given-names>B</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>A standardized social preference protocol for measuring social deficits in mouse models of autism</article-title>. <source>Nat Protoc</source>. (<year>2020</year>) <volume>15</volume>:<page-range>3464&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41596-020-0382-9</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spijker</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Neuroproteomics</article-title>. <source>Neuromethods</source>. (<year>2011</year>) <volume>57</volume>:<fpage>13</fpage>&#x2013;<lpage>26</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-61779-111-6_2</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strober</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Trypan blue exclusion test of cell viability</article-title>. <source>Curr Protoc Immunol</source>. (<year>2015</year>) <volume>111</volume>:<fpage>A3</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/0471142735.ima03bs111</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moaaz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Youssry</surname> <given-names>S</given-names>
</name>
<name>
<surname>Elfatatry</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rahman</surname> <given-names>MAE</given-names>
</name>
</person-group>. <article-title>Th17/Treg cells imbalance and their related cytokines (IL-17, IL-10 and TGF-&#x3b2;) in children with autism spectrum disorder</article-title>. <source>J Neuroimmunol</source>. (<year>2019</year>) <volume>337</volume>:<elocation-id>577071</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jneuroim.2019.577071</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faul</surname> <given-names>F</given-names>
</name>
<name>
<surname>Erdfelder</surname> <given-names>E</given-names>
</name>
<name>
<surname>Buchner</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lang</surname> <given-names>A-G</given-names>
</name>
</person-group>. <article-title>Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses</article-title>. <source>Behav Res Methods</source>. (<year>2009</year>) <volume>41</volume>:<page-range>1149&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3758/brm.41.4.1149</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gignac</surname> <given-names>GE</given-names>
</name>
<name>
<surname>Szodorai</surname> <given-names>ET</given-names>
</name>
</person-group>. <article-title>Effect size guidelines for individual differences researchers</article-title>. <source>Pers Individ Differ</source>. (<year>2016</year>) <volume>102</volume>:<page-range>74&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.paid.2016.06.069</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tannenbaum</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bennett</surname> <given-names>BT</given-names>
</name>
</person-group>. <article-title>Russell and Burch&#x2019;s 3Rs then and now: the need for clarity in definition and purpose</article-title>. <source>J Am Assoc Lab Anim Sci: JAALAS</source>. (<year>2015</year>) <volume>54</volume>:<page-range>120&#x2013;32</page-range>.</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jim&#xe9;nez</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Zylka</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>Controlling litter effects to enhance rigor and reproducibility with rodent models of neurodevelopmental disorders</article-title>. <source>J Neurodev Disord</source>. (<year>2021</year>) <volume>13</volume>:<elocation-id>2</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s11689-020-09353-y</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeiss</surname> <given-names>CJ</given-names>
</name>
</person-group>. <article-title>Comparative milestones in rodent and human postnatal central nervous system development</article-title>. <source>Toxicol Pathol</source>. (<year>2021</year>) <volume>49</volume>:<page-range>1368&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/01926233211046933</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaboski</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Storch</surname> <given-names>EA</given-names>
</name>
</person-group>. <article-title>Comorbid autism spectrum disorder and anxiety disorders: a brief review</article-title>. <source>Futur Neurol</source>. (<year>2018</year>) <volume>13</volume>:<page-range>31&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2217/fnl-2017-0030</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>He</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Synaptopathology involved in autism spectrum disorder</article-title>. <source>Front Cell Neurosci</source>. (<year>2018</year>) <volume>12</volume>:<elocation-id>470</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fncel.2018.00470</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akoglu</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>User&#x2019;s guide to correlation coefficients</article-title>. <source>Turk J Emerg Med</source>. (<year>2018</year>) <volume>18</volume>:<page-range>91&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tjem.2018.08.001</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arakawa</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>From multisensory assessment to functional interpretation of social behavioral phenotype in transgenic mouse models for autism spectrum disorders</article-title>. <source>Front Psychiatry</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>592408</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpsyt.2020.592408</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panzenhagen</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Cavalcanti</surname> <given-names>A</given-names>
</name>
<name>
<surname>Stein</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>de Castro</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Vasconcelos</surname> <given-names>M</given-names>
</name>
<name>
<surname>Abreu</surname> <given-names>MB</given-names>
</name>
<etal/>
</person-group>. <article-title>Behavioral manifestations in rodent models of autism spectrum disorder: protocol for a systematic review and network meta-analysis</article-title>. <source>Syst Rev</source>. (<year>2022</year>) <volume>11</volume>:<fpage>150</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13643-022-02028-w</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasumatsu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nagao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Arita-Morioka</surname> <given-names>K</given-names>
</name>
<name>
<surname>Narita</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tasaki</surname> <given-names>S</given-names>
</name>
<name>
<surname>Toyoda</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Bacterial-induced maternal interleukin-17A pathway promotes autistic-like behaviors in mouse offspring</article-title>. <source>Exp Anim Tokyo</source>. (<year>2020</year>) <volume>69</volume>:<page-range>250&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1538/expanim.19-0156</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicolini</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fahnestock</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The valproic acid-induced rodent model of autism</article-title>. <source>Exp Neurol</source>. (<year>2018</year>) <volume>299</volume>:<page-range>217&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.expneurol.2017.04.017</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manjeese</surname> <given-names>W</given-names>
</name>
<name>
<surname>Mvubu</surname> <given-names>NE</given-names>
</name>
<name>
<surname>Steyn</surname> <given-names>AJC</given-names>
</name>
<name>
<surname>Mpofana</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Mycobacterium tuberculosis-induced maternal immune activation promotes autism-like phenotype in infected mice offspring</article-title>. <source>Int J Environ Res Pu</source>. (<year>2021</year>) <volume>18</volume>:<elocation-id>4513</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijerph18094513</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quagliato</surname> <given-names>LA</given-names>
</name>
<name>
<surname>de</surname> <given-names>MU</given-names>
</name>
<name>
<surname>Nardi</surname> <given-names>AE</given-names>
</name>
</person-group>. <article-title>Maternal immune activation generates anxiety in offspring: A translational meta-analysis</article-title>. <source>Transl Psychiat</source>. (<year>2021</year>) <volume>11</volume>:<fpage>245</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41398-021-01361-3</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#x105;ssowska-Dobrowolska</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cie&#x15b;lik</surname> <given-names>M</given-names>
</name>
<name>
<surname>Czapski</surname> <given-names>GA</given-names>
</name>
<name>
<surname>J&#x119;&#x15b;ko</surname> <given-names>H</given-names>
</name>
<name>
<surname>Frontczak-Baniewicz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gewartowska</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Prenatal exposure to valproic acid affects microglia and synaptic ultrastructure in a brain-region-specific manner in young-adult male rats: relevance to autism spectrum disorders</article-title>. <source>Int J Mol Sci</source>. (<year>2020</year>) <volume>21</volume>:<elocation-id>3576</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21103576</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Um</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Differentially altered social dominance- and cooperative-like behaviors in Shank2- and Shank3-mutant mice</article-title>. <source>Mol Autism</source>. (<year>2020</year>) <volume>11</volume>:<fpage>87</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13229-020-00392-9</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taleb</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Q-G</given-names>
</name>
<name>
<surname>Naveed</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment</article-title>. <source>BioMed Pharmacother</source>. (<year>2021</year>) <volume>137</volume>:<elocation-id>111322</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2021.111322</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammadkhani</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ghahremani</surname> <given-names>R</given-names>
</name>
<name>
<surname>Salehi</surname> <given-names>I</given-names>
</name>
<name>
<surname>Safari</surname> <given-names>S</given-names>
</name>
<name>
<surname>Karimi</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Zarei</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Impairment in social interaction and hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in a prenatal valproic acid-induced rat model of autism</article-title>. <source>Brain Commun</source>. (<year>2022</year>) <volume>4</volume>:<elocation-id>fcac221</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/braincomms/fcac221</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balderaz</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Social skills interventions for adults with ASD: A review of the literature</article-title>. <source>J Psychosoc Rehabil Ment Heal</source>. (<year>2020</year>) <volume>7</volume>:<fpage>45</fpage>&#x2013;<lpage>54</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40737-020-00158-9</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radley</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Dart</surname> <given-names>EH</given-names>
</name>
<name>
<surname>Brennan</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Helbig</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Lehman</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Silberman</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Social skills teaching for individuals with autism spectrum disorder: a systematic review</article-title>. <source>Adv Neurodev Disord</source>. (<year>2020</year>) <volume>4</volume>:<page-range>215&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s41252-020-00170-x</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soares</surname> <given-names>EE</given-names>
</name>
<name>
<surname>Bausback</surname> <given-names>K</given-names>
</name>
<name>
<surname>Beard</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Higinbotham</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bunge</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Gengoux</surname> <given-names>GW</given-names>
</name>
</person-group>. <article-title>Social skills training for autism spectrum disorder: a meta-analysis of in-person and technological interventions</article-title>. <source>J Technol Behav Sci</source>. (<year>2021</year>) <volume>6</volume>:<page-range>166&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s41347-020-00177-0</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders</article-title>. <source>Mediat Inflammation</source>. (<year>2015</year>) <volume>2015</volume>:<elocation-id>531518</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2015/531518</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>W</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Association of peripheral blood levels of cytokines with autism spectrum disorder: A meta-analysis</article-title>. <source>Front Psychiatry</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>670200</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpsyt.2021.670200</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saghazadeh</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ataeinia</surname> <given-names>B</given-names>
</name>
<name>
<surname>Keynejad</surname> <given-names>K</given-names>
</name>
<name>
<surname>Abdolalizadeh</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hirbod-Mobarakeh</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rezaei</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude</article-title>. <source>J Psychiatr Res</source>. (<year>2019</year>) <volume>115</volume>:<fpage>90</fpage>&#x2013;<lpage>102</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2019.05.019</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filiano</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tustison</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Marsh</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Baker</surname> <given-names>W</given-names>
</name>
<name>
<surname>Smirnov</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Unexpected role of interferon-&#x3b3; in regulating neuronal connectivity and social behaviour</article-title>. <source>Nature</source>. (<year>2016</year>) <volume>535</volume>:<page-range>425&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature18626</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lampiasi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bonaventura</surname> <given-names>R</given-names>
</name>
<name>
<surname>Deidda</surname> <given-names>I</given-names>
</name>
<name>
<surname>Zito</surname> <given-names>F</given-names>
</name>
<name>
<surname>Russo</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Inflammation and the potential implication of macrophage-microglia polarization in human ASD: an overview</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>24</volume>:<elocation-id>2703</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms24032703</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pendyala</surname> <given-names>G</given-names>
</name>
<name>
<surname>Chou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Coiro</surname> <given-names>P</given-names>
</name>
<name>
<surname>Spartz</surname> <given-names>E</given-names>
</name>
<name>
<surname>Padmashri</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal immune activation causes behavioral impairments and altered cerebellar cytokine and synaptic protein expression</article-title>. <source>Neuropsychopharmacology</source>. (<year>2017</year>) <volume>42</volume>:<page-range>1435&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/npp.2017.7</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haida</surname> <given-names>O</given-names>
</name>
<name>
<surname>Sagheer</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Balbous</surname> <given-names>A</given-names>
</name>
<name>
<surname>Francheteau</surname> <given-names>M</given-names>
</name>
<name>
<surname>Matas</surname> <given-names>E</given-names>
</name>
<name>
<surname>Soria</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Sex-dependent behavioral deficits and neuropathology in a maternal immune activation model of autism</article-title>. <source>Transl Psychiat</source>. (<year>2019</year>) <volume>9</volume>:<fpage>124</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41398-019-0457-y</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergdolt</surname> <given-names>L</given-names>
</name>
<name>
<surname>Dunaevsky</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Brain changes in a maternal immune activation model of neurodevelopmental brain disorders</article-title>. <source>Prog Neurobiol</source>. (<year>2019</year>) <volume>175</volume>:<fpage>1</fpage>&#x2013;<lpage>19</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pneurobio.2018.12.002</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cie&#x15b;lik</surname> <given-names>M</given-names>
</name>
<name>
<surname>G&#x105;ssowska-Dobrowolska</surname> <given-names>M</given-names>
</name>
<name>
<surname>J&#x119;&#x15b;ko</surname> <given-names>H</given-names>
</name>
<name>
<surname>Czapski</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Wilkaniec</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zawadzka</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal immune activation induces neuroinflammation and cortical synaptic deficits in the adolescent rat offspring</article-title>. <source>Int J Mol Sci</source>. (<year>2020</year>) <volume>21</volume>:<elocation-id>4097</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21114097</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peralta</surname> <given-names>F</given-names>
</name>
<name>
<surname>Fuentealba</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fiedler</surname> <given-names>J</given-names>
</name>
<name>
<surname>Aliaga</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Prenatal valproate treatment produces autistic-like behavior and increases metabotropic glutamate receptor 1A-immunoreactivity in the hippocampus of juvenile rats</article-title>. <source>Mol Med Rep</source>. (<year>2016</year>) <volume>14</volume>:<page-range>2807&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2016.5529</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCarthy</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Wright</surname> <given-names>CL</given-names>
</name>
</person-group>. <article-title>Convergence of sex differences and the neuroimmune system in autism spectrum disorder</article-title>. <source>Biol Psychiat</source>. (<year>2017</year>) <volume>81</volume>:<page-range>402&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopsych.2016.10.004</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breach</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Lenz</surname> <given-names>KM</given-names>
</name>
</person-group>. <article-title>Sex differences in neurodevelopmental disorders: A key role for the immune system</article-title>. <source>Curr Top Behav Neurosci</source>. (<year>2022</year>) <volume>62</volume>:<fpage>165</fpage>&#x2013;<lpage>206</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/7854_2022_308</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinares-Garcia</surname> <given-names>P</given-names>
</name>
<name>
<surname>Stratikopoulos</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zagato</surname> <given-names>A</given-names>
</name>
<name>
<surname>Loke</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Sex: A significant risk factor for neurodevelopmental and neurodegenerative disorders</article-title>. <source>Brain Sci</source>. (<year>2018</year>) <volume>8</volume>:<elocation-id>154</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/brainsci8080154</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majerczyk</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ayad</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Brewton</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Saing</surname> <given-names>P</given-names>
</name>
<name>
<surname>Hart</surname> <given-names>PC</given-names>
</name>
</person-group>. <article-title>Systemic maternal inflammation promotes ASD via IL-6 and IFN-&#x3b3;</article-title>. <source>Biosci Rep</source>. (<year>2022</year>) <volume>42</volume>:<fpage>BSR20220713</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/bsr20220713</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>He</surname> <given-names>H</given-names>
</name>
<name>
<surname>Qiao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>T</given-names>
</name>
<name>
<surname>He</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Priming of microglia with IFN-&#x3b3; impairs adult hippocampal neurogenesis and leads to depression-like behaviors and cognitive defects</article-title>. <source>Glia</source>. (<year>2020</year>) <volume>68</volume>:<page-range>2674&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/glia.23878</pub-id>
</citation>
</ref>
<ref id="B102">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonz&#xe1;lez-Madrid</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rangel-Ram&#xed;rez</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Mendoza-Le&#xf3;n</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>&#xc1;lvarez-Mardones</surname> <given-names>O</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Kalergis</surname> <given-names>AM</given-names>
</name>
<etal/>
</person-group>. <article-title>Risk factors from pregnancy to adulthood in multiple sclerosis outcome</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<elocation-id>7080</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23137080</pub-id>
</citation>
</ref>
<ref id="B103">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onore</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Careaga</surname> <given-names>M</given-names>
</name>
<name>
<surname>Babineau</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Schwartzer</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Berman</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Ashwood</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Inflammatory macrophage phenotype in BTBR T+tf/J mice</article-title>. <source>Front Neurosci</source>. (<year>2013</year>) <volume>7</volume>:<elocation-id>158</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnins.2013.00158</pub-id>
</citation>
</ref>
<ref id="B104">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fung</surname> <given-names>LK</given-names>
</name>
<name>
<surname>Hardan</surname> <given-names>AY</given-names>
</name>
</person-group>. <article-title>Developing medications targeting glutamatergic dysfunction in autism: progress to date</article-title>. <source>CNS Drugs</source>. (<year>2015</year>) <volume>29</volume>:<page-range>453&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40263-015-0252-0</pub-id>
</citation>
</ref>
<ref id="B105">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eltokhi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Santuy</surname> <given-names>A</given-names>
</name>
<name>
<surname>Merchan-Perez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sprengel</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Glutamatergic dysfunction and synaptic ultrastructural alterations in schizophrenia and autism spectrum disorder: evidence from human and rodent studies</article-title>. <source>Int J Mol Sci</source>. (<year>2020</year>) <volume>22</volume>:<elocation-id>59</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms22010059</pub-id>
</citation>
</ref>
<ref id="B106">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Won</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mah</surname> <given-names>W</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses</article-title>. <source>Front Mol Neurosci</source>. (<year>2013</year>) <volume>6</volume>:<elocation-id>19</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnmol.2013.00019</pub-id>
</citation>
</ref>
<ref id="B107">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montanari</surname> <given-names>M</given-names>
</name>
<name>
<surname>Martella</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bonsi</surname> <given-names>P</given-names>
</name>
<name>
<surname>Meringolo</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Autism spectrum disorder: focus on glutamatergic neurotransmission</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<elocation-id>3861</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23073861</pub-id>
</citation>
</ref>
<ref id="B108">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howell</surname> <given-names>BW</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>KM</given-names>
</name>
</person-group>. <article-title>Synaptic structural protein dysfunction leads to altered excitation inhibition ratios in models of autism spectrum disorder</article-title>. <source>Pharmacol Res</source>. (<year>2019</year>) <volume>139</volume>:<page-range>207&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2018.11.019</pub-id>
</citation>
</ref>
<ref id="B109">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname> <given-names>C-C</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>L-S</given-names>
</name>
<name>
<surname>Long</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ke</surname> <given-names>X-Y</given-names>
</name>
<name>
<surname>Fukunaga</surname> <given-names>K</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>Y-M</given-names>
</name>
<etal/>
</person-group>. <article-title>Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications</article-title>. <source>Signal Transduct Target Ther</source>. (<year>2022</year>) <volume>7</volume>:<fpage>229</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-022-01081-0</pub-id>
</citation>
</ref>
<ref id="B110">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhuo</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Obstetric and offspring outcomes in isolated maternal hypothyroxinaemia: a systematic review and meta-analysis</article-title>. <source>J Endocrinol Investig</source>. (<year>2023</year>) <volume>46</volume>:<page-range>1087&#x2013;101</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40618-022-01967-4</pub-id>
</citation>
</ref>
<ref id="B111">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kansagra</surname> <given-names>SM</given-names>
</name>
<name>
<surname>McCudden</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Willis</surname> <given-names>MS</given-names>
</name>
</person-group>. <article-title>The challenges and complexities of thyroid hormone replacement</article-title>. <source>Lab Med</source>. (<year>2010</year>) <volume>41</volume>:<page-range>338&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1309/LMB39TH2FZGNDGIM</pub-id>
</citation>
</ref>
<ref id="B112">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fern&#xe1;ndez</surname> <given-names>MG</given-names>
</name>
</person-group>. <article-title>Hyperthyroidism and pregnancy</article-title>. <source>Endocrinol y Nutr (Engl Ed)</source>. (<year>2013</year>) <volume>60</volume>:<page-range>535&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.endoen.2013.11.008</pub-id>
</citation>
</ref>
<ref id="B113">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janecka</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kodesh</surname> <given-names>A</given-names>
</name>
<name>
<surname>Levine</surname> <given-names>SZ</given-names>
</name>
<name>
<surname>Lusskin</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Viktorin</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rahman</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of autism spectrum disorder with prenatal exposure to medication affecting neurotransmitter systems</article-title>. <source>JAMA Psychiatry</source>. (<year>2018</year>) <volume>75</volume>:<fpage>1217</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2018.2728</pub-id>
</citation>
</ref>
<ref id="B114">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kotajima-Murakami</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>M</given-names>
</name>
<name>
<surname>Katoh</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ikeda</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Influence of prenatal drug exposure, maternal inflammation, and parental aging on the development of autism spectrum disorder</article-title>. <source>Front Psychiatry</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>821455</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpsyt.2022.821455</pub-id>
</citation>
</ref>
<ref id="B115">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varela</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Vinet</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kamps</surname> <given-names>J</given-names>
</name>
<name>
<surname>Niditch</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Pre- and perinatal risk factors for youth with autism spectrum disorder versus youth with other mental health disorders</article-title>. <source>J Autism Dev Disord</source>. (<year>2023</year>) <volume>2023</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10803-022-05888-2</pub-id>
</citation>
</ref>
<ref id="B116">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takayama</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tobori</surname> <given-names>S</given-names>
</name>
<name>
<surname>Andoh</surname> <given-names>C</given-names>
</name>
<name>
<surname>Kakae</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hagiwara</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nagayasu</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Autism spectrum disorder model mice induced by prenatal exposure to valproic acid exhibit enhanced empathy-like behavior via oxytocinergic signaling</article-title>. <source>Biol Pharm Bull</source>. (<year>2022</year>) <volume>45</volume>:<page-range>1124&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1248/bpb.b22-00200</pub-id>
</citation>
</ref>
<ref id="B117">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sauer</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Hagmeyer</surname> <given-names>S</given-names>
</name>
<name>
<surname>Grabrucker</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>Prenatal zinc deficient mice as a model for autism spectrum disorders</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<elocation-id>6082</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23116082</pub-id>
</citation>
</ref>
<ref id="B118">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasahara</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>C</given-names>
</name>
<name>
<surname>Nakanishi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fukase</surname> <given-names>M</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kimura</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Alterations in the autonomic nerve activities of prenatal autism model mice treated with valproic acid at different developmental stages</article-title>. <source>Sci Rep</source>. (<year>2020</year>) <volume>10</volume>:<fpage>17722</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-74662-0</pub-id>
</citation>
</ref>
<ref id="B119">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horn</surname> <given-names>S</given-names>
</name>
<name>
<surname>Heuer</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Thyroid hormone action during brain development: More questions than answers</article-title>. <source>Mol Cell Endocrinol</source>. (<year>2010</year>) <volume>315</volume>:<fpage>19</fpage>&#x2013;<lpage>26</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mce.2009.09.008</pub-id>
</citation>
</ref>
<ref id="B120">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname> <given-names>GR</given-names>
</name>
</person-group>. <article-title>Neurodevelopmental and neurophysiological actions of thyroid hormone</article-title>. <source>J Neuroendocr</source>. (<year>2008</year>) <volume>20</volume>:<page-range>784&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2826.2008.01733.x</pub-id>
</citation>
</ref>
<ref id="B121">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Surcel</surname> <given-names>H-M</given-names>
</name>
<name>
<surname>Hinkka-Yli-Salom&#xe4;ki</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cheslack-Postava</surname> <given-names>K</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sourander</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source>. (<year>2015</year>) <volume>57</volume>:<fpage>86</fpage>&#x2013;<lpage>92</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pnpbp.2014.10.010</pub-id>
</citation>
</ref>
<ref id="B122">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jash</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>
<italic>In utero</italic> immune programming of autism spectrum disorder (ASD)</article-title>. <source>Hum Immunol</source>. (<year>2021</year>) <volume>82</volume>:<page-range>379&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.humimm.2021.02.002</pub-id>
</citation>
</ref>
<ref id="B123">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reed</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Yim</surname> <given-names>YS</given-names>
</name>
<name>
<surname>Wimmer</surname> <given-names>RD</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ryu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Welch</surname> <given-names>GM</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-17a promotes sociability in mouse models for neurodevelopmental disorders</article-title>. <source>Nature</source>. (<year>2020</year>) <volume>577</volume>:<page-range>249&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-019-1843-6</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>